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Regulatory Monopoly and Differential
Pricing in the Market for Patents
Neel U. Sukhatme*
Abstract
Patents are limited-term monopolies awarded to inventors to
incentivize innovation. But there is another monopoly that has
been largely overlooked at the heart of patent law: the monopoly of
the U.S. Patent and Trademark Office (PTO) over the granting of
patents. This Article addresses this topic by developing the notion
of a regulatory monopoly, where a single governmental actor has
the power to set prices in a regulatory area.
The Article explains how regulatory monopolists like the PTO
could enhance social welfare via differential pricing—by charging
regulated entities differing fees based on their willingness and
ability to pay. In particular, the Article shows how the PTO could
increase its revenues and promote innovation by charging
different patent “prices” for inventions in different industries.
Such pricing could also be used to tailor effective patent term
across industries, an emergent goal for many patent scholars.
The Article then applies the author’s recent empirical research
to generate potential differential patent price structures. This
research takes advantage of a natural experiment—a change in
patent term rules due to enactment of the TRIPS agreement in
1994—to measure the relative importance of patent protection
across different industries. The Article concludes by discussing
how recent patent reform (the America Invents Act of 2011)
provides a legal basis for the PTO to conduct differential pricing.
* Ph.D. Candidate (Economics), Princeton University; J.D., Harvard Law
School. The author thanks Orley Ashenfelter, Judd Cramer, Alan Devlin, Hank
Farber, Michael Frakes, David Lee, Mark Lemley, Katherine Strandburg, and
participants at the 2014 IP Scholars Conference (UC Berkeley), the Engelberg
Center on Innovation Law & Policy IP Luncheon (NYU School of Law), and
Princeton University’s Graduate Labor Seminar and Graduate Seminar in the
Program in Law and Public Affairs. All errors are the author’s own.
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I. Introduction
Patent law is inextricably tied to the economics of
monopolies, as patents are legal monopolies awarded to inventors
to incentivize innovation.1 By allowing an inventor to exclude
others from making, using, or selling his invention for a limited
period of time,2 patent law encourages the inventor to spend the
fixed costs necessary to generate the invention in the first place.
Unfortunately, patents often allow inventors to set higher prices
than would otherwise exist in a competitive market. This tradeoff
between incentivizing innovation and allowing monopoly pricing
is a fundamental and contentious topic debated by patent
scholars.3
Despite the centrality of monopoly to patent law, scholars
have largely overlooked another crucial role that monopoly plays
in the patenting process. This Article addresses that situation by
explaining how the U.S. Patent and Trademark Office
(PTO)―which is the sole regulatory entity charged with awarding
patents in the United States―has a monopoly over the granting of
patent rights.4 If patents are viewed as products in a market,
1. See 35 U.S.C. § 271(a) (2012). Although a legal monopoly often forms
the basis of an economic monopoly, the two concepts are distinct. See Richard A.
Posner, Intellectual Property: The Law and Economics Approach, 19 J. ECON.
PERSP. 57, 68 (2005) (“A legal monopoly is not necessarily an economic
monopoly; if close substitutes exist for a patented product, the patent may
confer little power over price.”).
2. See 35 U.S.C. § 271(a) (2012). A U.S. patent also enables an inventor to
prevent offers for sale of the patented invention within the United States, as
well as importation of the patented invention into the country. Id.
3. See, e.g., Gideon Parchomovsky & Michael Mattioli, Partial Patents,
111 COLUM. L. REV. 207, 213–19 (2011) (overviewing the evolution of scholarly
discussion concerning the various benefits and costs of patents); Alan O. Sykes,
Public Health and International Law: TRIPS, Pharmaceuticals, Developing
Countries, and the “Doha” Solution, 3 CHI. J. INT’L L. 47, 58 (2002) (noting that
“legislatures around the world have for centuries confronted the essential
monopoly/innovation tradeoff of the patent system”). “Although critics at times
suggest that patent protection is excessive, and others find it inadequate, there
is surely no consensus on the matter as a general proposition.” Id.
4. This point was nicely made in Michael B. Abramowicz & John H. Duffy,
Ending the Patenting Monopoly, 157 U. PA. L. REV. 1541 (2009), which is a rare
article discussing the PTO’s monopoly power. Abramowicz and Duffy focus on
ways in which the PTO could be demonopolized. See id. at 1579–1604 (offering
preliminary assessments of mechanisms used to demonopolize the patent
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then the PTO is the only place where they can be obtained. And
to receive patent protection, patent applicants and patentees
must pay the fees the PTO charges to fund its operations.5
More generally, this Article develops the concept of a
regulatory monopoly, where a single governmental actor has the
power to set prices in a regulatory area. The PTO is a
paradigmatic example of such a monopolist.6 It exercises its
regulatory monopoly powers when it mandates payments such as
maintenance fees, which are periodic payments a patentee must
make to prevent an already-issued patent from lapsing.7 The
Article discusses in detail the operation of the PTO and
highlights other regulatory monopolies at the federal, state, and
local levels.
Like a traditional monopolist, a regulatory monopolist can
engage in differential pricing by charging different amounts to
different people depending on how much they are willing to pay
and how much it costs to serve them.8 Unlike a traditional
monopolist, however, a regulatory monopolist ideally uses
differential pricing to further the public good. This Article
explains the prerequisites for differential pricing and discusses
market). I focus instead on how the PTO could use its monopoly power to set
differential prices to improve social welfare.
5. See 35 U.S.C. § 41 (listing numerous fees associated with patent
applications); see also Abramowicz & Duffy, supra note 4, at 1545–64 (describing
the PTO’s role as a government monopolist).
6. See Abramowicz & Duffy, supra note 4, at 1545 (stating that the PTO
has a monopoly over the granting of patents in the United States).
7. See 35 U.S.C. § 41(b) (providing for maintenance fees); see also USPTO
Fee Information: Current Fee Schedule, U.S. PATENT & TRADEMARK OFFICE,
http://www.uspto.gov/web/offices/ac/qs/ope/fee010114.htm (last visited Sept. 24,
2014) (providing maintenance fee payment schedules) (on file with the
Washington and Lee Law Review).
8. See Daniel J. Gifford & Robert T. Kudrle, The Law and Economics of
Price Discrimination in Modern Economies: Time for Reconciliation?, 43 U.C.
DAVIS L. REV. 1235, 1241–42 (2010) (discussing the varieties of differential
pricing). Economists also refer to differential pricing as price discrimination, of
which there are several types. See infra Part II.C.1 (discussing the prerequisites
for differential pricing). This Article is primarily concerned with a type known
as third-degree price discrimination, which involves charging people different
amounts based on their membership in a group. See William W. Fisher III,
When Should We Permit Differential Pricing of Information?, 55 UCLA L. REV.
1, 4 (2007).
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how regulatory monopolists can use such pricing to better fulfill
their regulatory goals.
Unfortunately, regulatory monopolies often fail to harness
the power of differential pricing. For instance, instead of
differentially pricing patents, the PTO charges patent applicants
and patentees uniform fees that do not depend on the underlying
invention type.9 This is inefficient because, as has been shown
empirically, inventors in different industries value patent rights
differently,10 and the PTO’s cost of reviewing patent applications
varies across industries.11
This Article explains how the PTO could instead use its
power as a regulatory monopoly to price patents differentially
across industries. Using insights from both neoclassical and
behavioral economics, the Article focuses on two different ways in
which the PTO could use differential pricing to enhance social
welfare: by lowering the cost of patenting and by customizing
patent term across industries.
First, differential pricing across industries, particularly with
respect to patent maintenance fees, would increase PTO
revenues.12 In particular, the PTO could increase maintenance
9. See 35 U.S.C. § 41 (setting uniform fees for patent applications).
10. See Neel U. Sukhatme & Judd N.L. Cramer, Who Cares About Patent
Term? Cross-Industry Differences in Term Sensitivity (Princeton Univ. Dep’t of
Econ., Working Paper, 2014), available at http://ssrn.com/abstract=2293245
(deriving empirical measures of the importance of patent term across
industries).
11. See Michael D. Frakes & Melissa F. Wasserman, Does Agency Funding
Affect Decisionmaking?: An Empirical Assessment of the PTO’s Granting
Patterns, 66 VAND. L. REV. 65 app. A, at 135–36 tbl.A1 (2013) [hereinafter
Frakes & Wasserman, PTO’s Granting Patterns] (listing the average number of
hours it takes to review a patent application along with the estimated cost for
patent applications within thirty-seven industry subcategories); see also Michael
D. Frakes & Melissa F. Wasserman, The Failed Promise of User Fees: Empirical
Evidence from the U.S. Patent and Trademark Office, 11 J. EMP. L. STUD. app. A,
tbl.A1 (forthcoming 2014) [hereinafter Frakes & Wasserman, Failed Promise]
(same).
12. Recent research suggests the PTO’s reliance on fees from patent
applicants and patentees to fund its operations might be financially straining
the organization, which in turn might cause a backlog in the processing of
patent applications. See generally Frakes & Wasserman, Failed Promise, supra
note 11 (arguing that certain fee schedules create financial risk that the PTO
will not cover its operational costs); Frakes & Wasserman, PTO’s Granting
Patterns, supra note 11, at 76 (arguing that the PTO is incentivized to grant
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fees on patentees in industries that, on average, care more about
patent protection. An increase in these late-stage fees would
enable the PTO to lower front-end patent application fees for
everyone, thereby reducing the total cost of patenting for most
applicants. Alternatively, the PTO could use the additional
revenues to improve its application review process, such as by
hiring more examiners to expedite review. To the extent we
believe heightened availability of patent protection or a more
efficient patent review process leads to more inventive activity,
differential patent pricing could promote innovation.13
Second, the Article explains how the PTO could use
differential pricing to tailor patent term across industries. In the
United States, patents receive a one-size-fits-all baseline term of
twenty years from the date of patent application filing. Many
scholars have recognized problems with this approach because a
uniform term seems at odds with the fact that the social costs and
benefits of patenting likely differ across industries. Accordingly,
some have suggested patent term should be tailored, with term
shortened for some categories of inventions.14
patents to make its revenue match its expenses). Part III, infra, discusses how
differential patent pricing has the potential to improve the PTO’s financial
standing and hence to alleviate the present backlog at the PTO.
13. This is not a settled point; some prominent commentators take the
strong view that patents do not incentivize innovation at all. See Michele
Boldrin & David K. Levine, The Case Against Patents, 27 J. ECON. PERSP. 3, 3
(2013) (“The case against patents can be summarized briefly: there is no
empirical evidence that they serve to increase innovation and productivity,
unless productivity is identified with the number of patents awarded—which, as
evidence shows, has no correlation with measured productivity.”).
14. See id. at 19 (“If the US economy is to have patents, we may want to
start tailoring their length and breadth to different sectoral needs. Substantial
empirical work needs to be done to implement this properly, although a vast
legal literature is already pointing in this direction.”). See generally Benjamin
N. Roin, The Case for Tailoring Patent Awards Based on the Time-to-Market of
Inventions, 61 UCLA L. REV. 672 (2014) (describing how patent length should be
tied to the public benefit). Cf. Dan L. Burk & Mark A. Lemley, Policy Levers in
Patent Law, 89 VA. L. REV. 1575 (2003) (discussing existing and potential policy
levers that courts use to apply patent laws in a technology-specific manner);
Dan L. Burk & Mark A. Lemley, Is Patent Law Technology-Specific?, 17
BERKELEY TECH. L.J. 1155 (2002) (claiming that although patent rules are
largely one-size-fits all, in practice, they are applied in a technology-specific
manner).
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This Article uses differential patent pricing to suggest a more
flexible and practical approach to term shortening: to reduce term
on patents within a particular industry, one could raise
maintenance fees on patents in that industry to the point where
patentees no longer renew their patents. In other words, if a
maintenance fee is sufficiently high for patentees in a particular
industry, then those patentees will stop paying this fee and their
patents will lapse. The Article highlights advantages of using
differential pricing to limit term in this manner, such as
increased flexibility to update prices as technology evolves,
heightened control over the number of patents within an industry
that terminate at a particular time, and ease of implementation
from a political economy standpoint.
Even though differential patent pricing is a potentially
powerful tool, it often requires the PTO to know certain
information. In particular, the PTO should know which
industries have patentees that, on average, care more about
patent protection. Put differently, the PTO needs an objective
measure of the relative value of patent protection across
industries. This Article reviews some of my recent empirical
research, which provides such a measure.15
In particular, my research exploits a natural experiment―the
1994 passage of the Agreement on Trade-Related Aspects of
Intellectual Property Rights (TRIPS).16 TRIPS changed the way
patent term was measured for the first time in over 130 years.
Before TRIPS, patent term was measured from the date a patent
was granted; after TRIPS, it was measured from the date a
patent application was filed.17 Thus, applicants in industries in
which patent term was more valuable were more likely to speed
up patent prosecution after TRIPS because the time an
application was pending would now cut into total patent term.
I use differences in the rate at which applicants sped up
prosecution across industry categories to create an industry-level
15. See generally Sukhatme & Cramer, supra note 10.
16. See Trade-Related Aspects of Intellectual Property Rights, PATENTLENS,
http://www.patentlens.net/daisy/patentlens/415.html (last visited Sept. 24,
2014) (describing rights and obligations under the TRIPS agreement) (on file
with the Washington and Lee Law Review).
17. See infra Part IV.A.1 (explaining how TRIPS changed term calculation).
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measure of patent term sensitivity. Applicants who care more
about patent term sped up more post-TRIPS vis-à-vis applicants
who cared less. This measure, along with another I have
developed and discuss in the Article,18 could be used to identify
categories of inventions for which applicants care more about
patent term. Once these categories are identified, the Article
shows how these empirical measures could be translated into
actual differential patent prices.
The final section of the Article tackles a crucial, underlying
legal question: Even if differential patent pricing is socially
optimal, is there a legal basis for implementing it? The Article
answers this question affirmatively, explaining how the PTO
recently gained fee-setting authority as part of the America
Invents Act (AIA), a comprehensive patent reform bill passed in
2011.19 In particular, § 10 of the AIA enables the PTO to alter its
fees to recover its aggregate estimated patent examination and
processing costs.20 The statutory language, as well as the PTO’s
recent interpretation of its fee-setting authority,21 indicates the

18. I generate two measures, both of which are highly correlated. The first
is the applicant delay measure described here. Infra Part IV.A.1. The second is
the ratio of patentees within a given industry that pay patent maintenance fees
to keep their patent in force after it has issued. Infra Part IV.A.2. Either of
these empirical measures could be used to generate differential patent prices.
19. See Leahy–Smith America Invents Act, Pub. L. 112-29, § 10(a)(1), 125
Stat. 284 (2011) (establishing and defining the PTO’s fee-setting authority).
20. See id. (“The Director may set or adjust by rule any fee established,
authorized, or charged under [patent law] for any services performed by or
materials furnished by the Office . . . only to recover the aggregate estimated
costs to the Office . . . .”). The PTO also has its own industry-level measure of
the amount of time allocated to patent processing, and Michael Frakes and
Melissa Wasserman have used this measure to generate an average measure of
examination costs across industry categories. See Frakes & Wasserman, PTO’s
Granting Patterns, supra note 11, app. A, at 135–36 tbl.A1 (listing average costs
by industry sub-category). This measure is highly correlated with my crossindustry patent sensitivity measure. In other words, the industries with
applications that take the most time (and cost the most) to evaluate are the
same industries with applicants who care the most about patent term. This
further bolsters the rationale for differential pricing.
21. See generally Setting and Adjusting Patent Fees, 78 Fed. Reg. 4211
(Jan. 18, 2013) (exercising the PTO’s new authority to set or adjust fees).
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agency has the power to differentially price patents based on
industry category.22
II. Regulatory Monopolies and Differential Pricing
A. The Concept of a Regulatory Monopoly
The PTO stands in a unique position as the only patentgranting institution in the United States.23 To receive a patent,
an applicant must apply to the PTO and pay all of its required
fees. As the sole gatekeeper of patent rights, the PTO has a
regulatory power that can be viewed as a monopoly. More
generally, this Article defines this sort of power as a regulatory
monopoly―a single locus of regulatory authority with the ability
to set prices on regulated actors.
22. This conclusion holds if the PTO uses differential pricing to alter its
revenue flow. It is less clear whether the PTO could differentially price patents
to effectively limit patent term for certain industries. This type of differential
pricing might require additional authorization from Congress. See infra Part V
(discussing the PTO’s authority to differentially set fees); see also note 227 and
accompanying text (addressing potential argument that TRIPS itself might limit
industry-specific tailoring of patent laws).
23. See 35 U.S.C. § 2 (2012) (granting the PTO exclusive authority to issue
patents and to register trademarks). An inventor who is denied patent rights by
the PTO can appeal the rejection to the U.S. Court of Appeals for the Federal
Circuit. See id. § 141 (allowing appeals to the Federal Circuit); see also Jonathan
Masur, Patent Inflation, 121 YALE L.J. 470, 473 (2011) (describing how potential
for appeal creates asymmetric incentives in favor of the PTO granting more
patents than it perhaps should). But this is very rare. For example, in fiscal
year 2013, only 132 cases were appealed to the Federal Circuit, and only 8% of
pending cases were reversed. U.S. CT. APP. FED. CIR., FISCAL YEAR 2013
STATISTICS, U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT—APPEALS FILED,
TERMINATED, AND PENDING DURING THE TWELVE-MONTH PERIOD ENDED
SEPTEMBER 30, 2013, http://www.cafc.uscourts.gov/images/stories/the-court/
statistics/FY13/appeals%20filed%20term%20pend%209.30.13.pdf. Compare that
with the 542,815 utility patent applications filed in calendar year 2012. U.S.
Patent Statistics Chart, Calendar Years 1963–2013, U.S. PATENT & TRADEMARK
OFFICE,
http://www.uspto.gov/web/offices/ac/ido/oeip/taf/us_stat.htm
(last
updated July 24, 2014) (last visited Sept. 24, 2014) [hereinafter U.S. Patent
Statistics Chart] (on file with the Washington and Lee Law Review).
Nonetheless, the presence of alternative routes to obtain patent protection in a
few cases does not change the analysis here—the PTO has a near monopoly on
the granting of patent rights. So long as the PTO has significant market power,
it can engage in differential patent pricing.
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A monopolist has market power because it is the sole seller of
a particular good or service.24 Customers cannot purchase that
good or service elsewhere, at least at comparable cost.25 For a
regulatory monopoly, the “good” at issue is regulatory approval.
In the case of the PTO, the good can be conceptualized as “patent
rights” over a particular inventive idea.
Unlike a traditional monopolist, a regulatory monopolist
(hopefully) does not give its regulatory approval simply in
response to receiving money or fees from a user. Rather, a
regulatory monopolist presumably makes its decisions based on
law and policy―should a regulated entity be allowed to perform a
certain action or be granted a particular right, taking into
account applicable laws and social welfare? While regulatory
monopolists need not charge their users anything, our focus here
is on government institutions that charge fees in addition to
exercising sole regulatory authority over a particular area.
Applying this definition, we can see the PTO is hardly unique
as a regulatory monopolist. Indeed, there are many examples of
regulatory monopolies at all levels of government. For example,
consider the Food and Drug Administration’s (FDA) role in
approving new drugs. Absent FDA approval, a pharmaceutical
company cannot sell, and a doctor cannot prescribe, a new drug
for treating a disease.26 So the FDA has the sole gatekeeping
authority in determining which drugs are approved. Moreover, as
part of its approval process, the FDA requires applicants to pay
fees.27 In the parlance of this Article, the FDA has a regulatory
24. See Phillip Areeda & Donald F. Turner, Predatory Pricing and Related
Practices Under Section 2 of the Sherman Act, 88 HARV. L. REV. 697, 702–03
(1975) (noting that a monopolist can control market price by varying its output).
The word “monopoly” comes from the Greek monopōlion, from monos, meaning
“single,” and pōlein, meaning “to sell.” MERRIAM-WEBSTER DICTIONARY (2014).
25. See Gifford & Kudrle, supra note 8, at 1244 (noting that the lack of
competition gives monopolies the power to control the price of goods and
services).
26. See Development and Approval Process (Drugs), U.S. FOOD & DRUG
ADMIN., http://www.fda.gov/drugs/developmentapprovalprocess/ (last updated
Aug. 19, 2014) (last visited Sept. 24, 2014) (detailing the FDA approval process)
(on file with the Washington and Lee Law Review).
27. See Elizabeth C. Price, Teaching the Elephant to Dance: Privatizing the
FDA Review Process, 51 FOOD DRUG L.J. 651, 652 (1996) (“For those companies
seeking to market new drugs, food additives, or medical devices, the FDA is the
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monopoly over the granting of new drug compounds in the United
States and the associated fees that companies seeking regulatory
approval must pay.
Regulatory monopolies also abound at the state level. For
example, states typically require people who wish to hunt or fish
to first obtain a license from a state wildlife agency.28 Without
such a permit, one cannot legally engage in these activities in the
state. These wildlife agencies generally charge users a fee for this
permit, and there is usually only one such agency in each state.
Accordingly, state wildlife agencies are examples of state-level
regulatory monopolists.
Local governments have regulatory monopolies as well.
When an individual seeks a building permit for a house, or a
license to operate a taxicab or to sell liquor in a city, she
generally must receive approval from a local government agency.
Such institutions often charge a fee for a permit, and these fees
can be quite substantial. These unitary local authorities also
exercise regulatory monopoly power because absent their
approval, the individual cannot engage in the regulated activity.
B. Other Regulatory Market Structures
While the concept of a regulatory monopoly is typically
overlooked,29 it fits into a more general discussion on “regulatory
only game in town.”). “As with any other monopolist, the FDA has unfettered
ability to raise the ‘price’ and limit the ‘supply’ of its services (i.e., product
approval), to force purchasers (i.e., product manufacturers) to engage in tying
arrangements, and to boycott or refuse to deal with regulated entities.” Id.
28. See Federal, State, and Provincial Wildlife Agencies, NAT’L WILD
TURKEY FED’N, http://www.nwtf.org/in_your_state/AllAgencies.html (last visited
Sept. 24, 2014) (listing state and federal wildlife agencies) (on file with the
Washington and Lee Law Review).
29. The concept has been recognized by some scholars, primarily relating to
the Securities and Exchange Commission. See, e.g., Chris Brummer, PostAmerican Securities Regulation, 98 CALIF. L. REV. 327, 382 (2010) (“Scholars
have long viewed the SEC as wielding a virtual regulatory monopoly over the
provision of securities laws both at home and abroad.”); Eric J. Pan,
Harmonization of U.S.–EU Securities Regulation: The Case for a Single
European Securities Regulator, 34 LAW & POL’Y INT’L BUS. 499, 527–28 (2003)
(“[Al]though the SEC has a regulatory monopoly over the U.S. securities
market, the SEC does not behave like a monopoly.”); see also David A. Hyman,
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competition,” which has been studied in more detail.30 For
example, there is a rich literature on the effect of state
competition in the context of corporate governance laws.31 This
competition arises because corporations can choose where to
incorporate, and the laws of the state of incorporation often
govern subsequent shareholder or other corporate litigation.32
Many scholars argue this competition has created incentives for
certain states to adopt more corporate-friendly laws to entice
companies to incorporate in their states.33 As a consequence,
states can get caught up in a “race to the bottom”—because
Health Insurance: Market Failure or Government Failure?, 14 CONN. INS. L.J.
307, 320–21 (2008) (discussing state regulatory monopolies over insurance
regulation); Price, supra note 27, at 652–53 (describing the FDA’s power to raise
prices, limit supply, and ultimately force manufacturers to engage in certain
behavior). See generally Frederick Tung, Lost in Translation: From U.S.
Corporate Charter Competition to Issuer Choice in International Securities
Regulation, 39 GA. L. REV. 525 (2005) (discussing regulatory monopoly and
regulatory price discrimination relating to corporate charters). More often,
“regulatory monopoly” has been used to describe monopolies generated by law
and awarded to public utility companies, such as AT&T. See, e.g., Christopher
Wyeth Kirkham, Note, Busting the Administrative Trust: An Experimentalist
Approach to Universal Service Administration, 98 COLUM. L. REV. 620, 624
(1998) (describing the divesture of AT&T Bell companies).
30. See, e.g., Brummer, supra note 29, at 382 (“Recent scholarship has
demonstrated that traditionally dominant regulators, like the SEC, have to
compete for transactions by offering attractive securities laws because foreign
markets have become more economically significant. This observation has
enabled a binary regulatory monopoly/competition framework for describing the
SEC’s regulatory power.”).
31. See, e.g., Lucian Arye Bebchuk, Federalism and the Corporation: The
Desirable Limits on State Competition in Corporate Law, 105 HARV. L. REV.
1435, 1437 (1992) (arguing that state competition fails in certain aspects of
corporate law, and advocating greater federal intervention in corporate law);
Frank H. Easterbrook, Managers’ Discretion and Investors’ Welfare: Theories
and Evidence, 9 DEL. J. CORP. L. 540, 549–50 (1984) (arguing that state
competition leads to more effective corporate law).
32. See William L. Cary, Federalism and Corporate Law: Reflections Upon
Delaware, 83 YALE L.J. 663, 663–68 (1974) (discussing the historical evolution of
state corporate law).
33. See id. at 668 (describing Delaware as a state that draws most of its
revenue from corporations). Reasons why states might want to become a locus
for incorporation include the franchise fees that corporations must pay and the
extra legal work it generates for the local bar. See id. (arguing that the “raison
d’etre” for Delaware’s corporate-friendly legal atmosphere is revenue for the
state).
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companies can choose among many states where to incorporate,
they pick ones with more lax governance rules, which in turn
incentivizes states to lower governance standards further.34
Other regulatory market structures may fall between a
regulatory monopoly and regulatory competition. To illustrate,
consider premerger regulation under the Hart–Scott–Rodino
Antitrust Improvements Act (HSR).35 Prior to certain mergers or
tender offers, the parties involved must file a report with two
separate regulatory agencies―the Federal Trade Commission
(FTC) and the Antitrust Division of the Department of Justice
(DOJ Antitrust). If either the FTC or DOJ Antitrust believes the
proposed
transaction
has
significant
anticompetitive
consequences, then either agency can request more information
and block the merger.36 Moreover, the party proposing the
acquisition must pay a large fee, set by the FTC, depending on
the size of the proposed transaction.37
34. See id. (portraying Delaware law as favorable because of its judiciary
and body of case law). Other scholars claim that managers of corporations
compete with one another in a way that actually generates a race to the top. See
generally Ralph K. Winter, Jr., State Law, Shareholder Protection, and the
Theory of the Corporation, 6 J. LEGAL STUD. 251 (1977); see also Robert B.
Ahdieh, Trapped in a Metaphor: The Limited Implications of Federalism for
Corporate Governance, 77 GEO. WASH. L. REV. 255, 256–57 (2009) (arguing that
discussion on whether federalism leads to a race to the bottom or a race to the
top in corporate law is misguided); Mark J. Roe, Delaware’s Competition, 117
HARV. L. REV. 588, 610–12 (2003) (arguing that federal law, not other states’
laws, is the primary competition for Delaware corporate law); Marcel Kahan &
Ehud Kamar, The Myth of State Competition in Corporate Law, 55 STAN. L. REV.
679, 681 (2002) (“Race-to-the-top scholars argue that companies incorporate
where their value is the highest and that states accordingly compete by offering
laws that afford optimal shareholder protection.”).
35. See Steven K. Bernstein & Jeff L. White, Federal Antitrust Review of
Generic Drug Mergers: A Proposal for a More Flexible Approach, 4 N.Y.U. J.L. &
BUS. 465, 466–68 (2008) (laying out the notification, filing fee, and other
statutory requirements of HSR).
36. See id. (describing the statutory waiting period where the FTC and
DOJ analyze the proposed transaction).
37. As of February 2013, the HSR fee was $45,000 for transactions between
$70.9 and $141.8 million, $125,000 for transactions between $141.8 and $709.1
million, and $280,000 for transactions over $709.1 million. FTC Premerger
Notification Program, Filing Fee Information, FED. TRADE COMM’N (Feb. 24,
2014), http://www.ftc.gov/enforcement/premerger-notification-program/filing-feeinformation (last visited Sept. 24, 2014) (on file with the Washington and Lee
Law Review).
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Because the FTC and DOJ Antitrust both have a veto over a
potential merger, their regulatory power is not as complete as
that of a regulatory monopolist such as the PTO. For example, if
DOJ Antitrust generally favors mergers but the FTC is
antimerger, then the FTC might hinder the DOJ’s ability to allow
what it perceives are socially beneficial mergers.38 This
“regulatory duopoly” structure forces its two “competitor”
regulators to consider each other’s actions when determining
their own policy.39
C. The Economics of Differential Pricing
Monopolies often (deservedly) have a bad reputation. But
regulatory monopolies like the PTO have the potential to use
their monopoly power to fulfill their regulatory purpose and
promote the general good. Much of the positive potential of
38. Concerns about regulatory competition between the FTC and DOJ
Antitrust have been minimal in recent years as the agencies have agreements
and clearance procedures with one another to prevent stepping on each other’s
toes. U.S. DEP’T OF JUSTICE, ANTITRUST DIVISION, ANTITRUST DIVISION MANUAL,
VII-3–VII-8 (5th ed. 2014); see also Fred S. McChesney, Talking ‘Bout My
Antitrust Generation: Competition for and in the Field of Competition Law, 52
EMORY L.J. 1401, 1426 n.106 (2003) (referencing the recent harmony between
the FTC and DOJ). The two agencies also specialize in different areas. See, e.g.,
COMM’N,
The
Enforcers:
The
Federal
Government,
FED. TRADE
http://www.ftc.gov/tips-advice/competition-guidance/guide-antitrust-laws/ enforcers
(last visited Sept. 24, 2014) (“Both the FTC and [DOJ Antitrust] enforce the
federal antitrust laws. In some respects their authorities overlap, but in practice
the two agencies complement each other. Over the years, the agencies have
developed expertise in particular industries or markets.”) (on file with the
Washington and Lee Law Review). Nonetheless, the potential for conflicts
between the two regulatory agencies still exists. See Mark D. Whitener, Advice,
Unsolicited, 22 ANTITRUST ABA 6, 6 (2008) (“[T]he ‘dual enforcement’ debate
may be quiet for now, but it is never far from the surface.”).
39. See McChesney, supra note 38, at 1426 n.106 (noting that the FTC and
DOJ Antitrust divided their regulatory authority, assigning each industry to
one enforcement agency or the other). The FTC’s and DOJ Antitrust’s merger
authority differs in one important way from a standard duopoly, as regulated
parties cannot select the agency that regulates them. In other words, unlike a
buyer who can choose from one of two sellers, merging companies are subject to
regulation by both regulatory agencies. Nonetheless, conceptualizing this
market as a regulatory duopoly helps us see how the actions of one agency affect
another tasked at regulating the same conduct.
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regulatory monopolies stems from their ability to conduct
differential pricing. To fully understand how this works requires
a brief primer on the economics of monopolies and differential
pricing, which is the topic of this subpart.
1. Prerequisites for Differential Pricing
A regulatory monopoly like the one enjoyed by the PTO
allows it to exercise more individualized forms of regulatory
power. In particular, because the PTO controls the flow of patent
rights, and because it recently gained some ability to control the
fees it charges patent applicants, it can tailor some of the fees
that it charges based on underlying characteristics of the
applicant.40 It can charge more to certain applicants (e.g., those
whose patent applications cost more to process or those who care
more about patent rights) than to others (e.g., those whose
applications cost less to process or those who care less about
patent rights). In economic terms, this is referred to as price
discrimination or differential pricing.41
Differential pricing works because buyers differ in their
willingness to pay for certain goods. To illustrate, consider the
market for a new type of tennis racquet with a better balance of
control and power than existing brands. Suppose it costs me, the
racquet manufacturer, $100 to produce each additional racquet;
in economics terms, we say the marginal cost of each racquet is
$100. Additionally, assume that potential consumers of this new
racquet fall into four camps differentiated by the amount they
would be willing to pay. Group 1 would be willing to pay $200;
40. See generally Gifford & Kudrle, supra note 8 (discussing generally the
economics of price discrimination).
41. Despite the negative connotation of the term “price discrimination,” it is
not necessarily a bad thing. As explained below, in many situations, price
discrimination can increase social welfare by increasing the number of beneficial
transactions that take place. See, e.g., Patricia M. Danzon & Adrian Towse,
Differential Pricing for Pharmaceuticals: Reconciling Access, R&D, and Patents,
3 INT’L J. HEALTHCARE FIN. & ECON. 183, 184–87 (2003) (explaining how
differential pricing could make on-patent drugs affordable in developing
countries). In other words, absent price discrimination, some people who would
like to purchase a good or service would be priced out of the market.
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group 2, $150; group 3, $120; and group 4 would pay nothing at
all.
How would pricing work if this were a perfectly competitive
market?42 Basic economics teaches us that in such a market, the
maximum price a seller can charge depends on the price other
sellers charge. If a competitor undercuts me, I am forced to lower
my price or else customers will buy from the competitor instead.
Sellers will compete with one another to lower the price until it
reaches the marginal cost of the good.43 At that point, sellers will
not lower the price any further as doing so would result in selling
the product at a loss, and it would be better to sell nothing rather
than to sell at a loss. So in the tennis racquet example described
above, the price in a perfectly competitive market would be $100,
and people in groups 1, 2, and 3 would buy the racquet (and
people in group 4 would not).
Accordingly, in a competitive market, there is no room for
differential pricing. A basic law of economics—the law of one
price44―governs, and the market-clearing price will not depend on
consumers’ willingness to pay for a product. The price will be the
marginal cost of the good.45
42. A perfectly competitive market is one in which no producer of a
particular good is large enough to exert market power over the price of the good.
See Israel M. Kirzner, Entrepreneurial Discovery and the Competitive Market
Process: An Austrian Approach, 35 J. ECON. LIT. 60, 63 (1997) (describing a
perfectly competitive market in microeconomics as one where no actor dictates
price). In the context of tennis racquets, a perfectly competitive market might be
approximated by one in which multiple competitors are able to copy the design
of the racquet only after any patents on its structure have expired.
43. See Areeda & Turner, supra note 24, at 702 (noting that firms in a
perfectly competitive market maximize profits by increasing output to the point
where marginal cost equals the market price).
44. The law of one price provides that the same good must sell for the same
price in all locations. See Owen A. Lamont & Richard H. Thaler, Anomalies: The
Law of One Price In Financial Markets, 17 J. ECON. PERSP. 191, 191 (2003) (“The
Law [of one price] states that identical goods must have identical prices.”). If the
law did not hold true, then one could make unlimited profits by buying the item
in the cheaper location and reselling it in the more expensive location. Doing
this would increase the demand for the item in the cheaper location (thereby
raising the price there) and increase the supply of the item in the more
expensive location (thereby lowering the price there) until the two prices were
equal. See id. at 192 (describing this phenomenon as arbitrage—the ability of
individuals to purchase a product in one market and sell it in another).
45. See Areeda & Turner, supra note 24, at 702 (noting that this is the
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When there is a monopoly, (or more generally, when a seller
has some market power) however, pricing decisions change. As a
monopolist, I do not have to worry about what my competitors
will charge because I do not have any competitors.46 Instead, my
pricing depends solely on my customers’ willingness to pay, along
with the cost of producing the good. In the language of economics,
the market-clearing price is one in which the marginal cost of the
good equals the revenue generated from producing one additional
unit of the good. That is, a monopolist produces goods such that
marginal cost equals marginal revenue.47
An important corollary to this point is that, in a monopoly,
customers who would otherwise buy a product in a competitive
market are priced out of the market.48 To illustrate this
phenomenon more concretely, suppose I have some degree of
monopoly power in the tennis racquet market discussed above.49
Instead of setting a price of $100 (the marginal cost), I instead
calculate that I can use my market power to maximize my profits
by pricing my racquet above marginal cost, at $150. In that case,
people in groups 1 and 2 would buy my racquet, but people in
group 3 would not.
Note that this outcome is not the best one for the
monopolist—it costs him only $100 to produce the racquet, and
the individuals in group 3 would be willing to pay $120 for it, but
because the price is $150, they never purchase it. But if the
monopolist charges $120 instead of $150, he will be losing money
point at which firms in a competitive market will maximize profit).
46. As a practical matter, I almost always have some competitors—it is just
a matter of degree. For example, even if a company had a monopoly over all
forms of automotive transportation, some people would still have alternate
means of travel, such as riding a bike, taking the train, or walking. So demand
for automobiles is not completely inelastic, and if the price of driving were high
enough, people who would otherwise drive would shift over to other modes of
transportation.
47. See William M. Landes & Richard A. Posner, Market Power in Antitrust
Cases, 94 HARV. L. REV. 937, 939 (1981) (noting that the point where marginal
cost equals marginal revenue is profit-maximizing for monopolies).
48. See Peter Lee, The Evolution of Intellectual Infrastructure, 83 WASH. L.
REV. 39, 98 n.323 (2008) (explaining that super-competitive pricing drives out
consumers from a market).
49. For example, if I have a patent over the structure of the tennis racquet,
I can prevent competitors from copying the design.
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on the people in groups 1 and 2, who would be willing to pay $200
and $150, respectively. So what should the monopolist do?
If the monopolist has information on his customers’
willingness to pay, he could charge each customer a different
amount for the racquet. In other words, the monopolist could
charge the individuals in group 1, $200; individuals in group 2,
$150; and individuals in group 3, $120. This is the essence of
differential pricing―charging people different prices that reflect
their differing willingness to pay.
Put differently, differential pricing allows the monopolist to
get the best of both worlds. The monopolist can sell to all people
who value the good at issue more than the marginal cost—in the
case of the tennis racquet, that is people in groups 1, 2, and 3. At
the same time, he can charge more to people who want the
product more. Thus, differential pricing enables a monopolist to
maximize his revenues while selling to all customers who value
the product more than the cost of producing it.50
To price differentially, however, having market power and
information on people’s willingness to purchase is not enough. A
monopolist must also be able to block buyers of his product from
selling to one another.51 For instance, even if a monopolist
correctly identified consumers by their willingness to pay, a group
3 person could buy a tennis racquet for $120 and turn around and
resell it to a group 2 person for somewhere between $120 and
$150. Both the group 3 person and the group 2 person would be
better off by this transaction than if the group 2 person simply
bought the racquet from the monopolist for $150.52 So differential

50. See Richard A. Posner, Natural Monopoly and Its Regulation, 21 STAN.
L. REV. 548, 570 (1969) (arguing that price discrimination may be the only
feasible method of ensuring efficient allocation of resources under conditions of
natural monopoly).
51. See Michael J. Meurer, Copyright Law and Price Discrimination, 23
CARDOZO L. REV. 55, 59 (2001) (discussing the requirements for price
discrimination and explaining why it cannot be met in many markets).
52. See R.H. Coase, The Problem of Social Cost, 3 J.L. & ECON. 1, 15 (1960)
(articulating the Coase theorem—the idea that, absent transaction costs, private
parties will bargain to place goods in the hands of the person who values the
goods the most).
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pricing works only if a seller can block arbitrage—if it can block
buyers of products from selling to one another.53
2. Varieties of Differential Pricing
Market power, information on customers’ willingness to pay,
and the ability to block arbitrage give sellers the power to engage
in differential pricing (or as it is often called, price
discrimination).54 As scholars have recognized, there are three
major types of differential pricing: first-degree, second-degree,
and third-degree price discrimination.55
First-degree price discrimination is the most direct kind of
differential pricing. Here, a seller charges each buyer a different
price that corresponds to that buyer’s willingness to pay.56 Firstdegree price discrimination is more of a theoretical benchmark,
as it is generally impossible for a seller to know each buyer’s
exact valuation of a product.57 In the tennis racquet example
above, first-degree price discrimination would occur if the seller
knew the exact willingness to pay for all his potential customers.
Second-degree price discrimination involves a situation
where a seller cannot determine on its own how much potential
buyers are willing to pay for its product.58 Nonetheless, the seller
is able to provide incentives to consumers that cause them to
signal their willingness to buy through their purchasing
decisions.59
53. See Fisher, supra note 8, at 3–9 (stating that price discrimination is
hard to do because a firm must have market power, arbitrage must be limited,
and the firm must be able to differentiate between consumers).
54. See id. at 3–4 (listing the three prerequisites to differential pricing).
55. See Gifford & Kudrle, supra note 8, at 1241 (discussing the three types
of differential pricing).
56. See Meurer, supra note 51, at 68–69 (“In the idealized case of perfect (or
first degree) price discrimination the seller can block arbitrage and transact at a
different price with each buyer.”).
57. See Gifford & Kudrle, supra note 8, at 1241 (noting that first-degree
price discrimination occurs only in rare, specialized circumstances).
58. See Meurer, supra note 51, at 71–80 (describing how in second-degree
price discrimination sellers measure preferences by observing buyers’ choices).
59. See Gifford & Kudrle, supra note 8, at 1241 (noting that a common
second-degree price discrimination technique is two-tiered pricing, where all
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A
quintessential
example
of
second-degree
price
discrimination is product versioning. Here, a seller provides
slightly different versions of a product that appeal to people who
differ in their willingness to pay.60 For example, suppose the
tennis racquet manufacturer ships the racquet in two versions―a
regular version, and a deluxe version that costs twice the price
but is signed by a star tennis player. Those who value the
autographed racquet will buy the deluxe version; those who care
only about receiving the racquet will buy the regular version. By
creating two different versions of the same racquet, the seller has
caused potential buyers to self-select into two different groups
that roughly correspond to their desire to buy the racquet.61
An advantage of second-degree price discrimination is that it
automatically handles concerns about arbitrage between
consumers. This is because versioning of the product is itself
what separates consumers who differ in their willingness to
pay.62 For example, an individual who is willing to pay for only
the regular version of the racquet will not buy the deluxe version
from someone who has bought it, and an individual who wants
the deluxe version will not buy the regular version from another
customer.
Third-degree price discrimination involves a seller
partitioning a market into segments and charging people within
each segment the same price.63 A common example of thirddegree price discrimination is student discounts. Companies often
know that students on average have less money than people who
consumers pay an initial fee to enter the market and then pay a flat fee per unit
purchased).
60. See Katherine J. Strandburg, Free Fall: The Online Market’s Consumer
Preference Disconnect, 2013 U. CHI. LEGAL F. 95, 136 (2013) (indicating that
second-degree price discrimination induces consumers to reveal their
willingness to pay).
61. See id. (stating that second-degree price discrimination induces
consumers to sort themselves by willingness to pay).
62. See Meurer, supra note 51, at 72–75 (discussing how second-degree
price discrimination prevents arbitrage by separating consumers based on
willingness to pay).
63. See id. at 69 (providing an example of third-degree price discrimination
that illustrates how segments are formed and how persons within each segment
pay the same price).

REGULATORY MONOPOLY

1875

work full-time. Accordingly, by charging students less, a company
is able to sell to students at a lower price (corresponding to their
lower willingness to pay) while still charging nonstudents a
higher price.64 So long as the students’ willingness to pay exceeds
the marginal cost of producing the good, this kind of differential
pricing is beneficial to the monopolist.65
One issue with third-degree price discrimination, as with
first-degree price discrimination, is that sellers must be able to
prevent arbitrage among consumers.66 So third-degree price
discrimination works well in environments in which sales of
goods between customers can be easily blocked. Airline tickets
are a good example. These tickets are generally nontransferable,
which means the airline will not honor the ticket if it is given or
sold to another person. Because a person’s identity is easily
verifiable when an individual boards a plane, third-degree price
discrimination works well in this setting.67
D. Differential Pricing in Regulatory Monopolies
The previous sections discussed differential pricing in the
context of traditional monopolies. But the same discussion
applies to any regulatory monopoly, such as the PTO, which has
market power over the prices it sets (user fees) on the goods it
64. See Strandburg, supra note 60, at 136 (noting that movie theaters often
engage in third-degree price discrimination by selling movie tickets at different
prices to adults, seniors, students, and children).
65. See Meurer, supra note 51, at 69–71 (explaining that a monopolist
produces a good to the point where marginal cost equals marginal revenue); see
also Fisher, supra note 8, at 4 (providing that senior discounts also exhibit
third-degree price discrimination in which the seller, despite a lack of
knowledge about purchasing power, can separate buyers into groups based upon
perceived wealth or eagerness).
66. See Meurer, supra note 51, at 68–71 (arguing that both first- and thirddegree price discrimination are subject to arbitrage limits).
67. Here, the price discrimination is between business and leisure
travelers. Airlines know business travelers often make travel plans with short
lead time and are relatively price insensitive. On the other hand, leisure
travelers can typically plan their trips much more in advance and are more
price sensitive. By selling airline tickets at a cheaper price a few weeks before a
flight, and then raising the price as the travel date gets closer, airlines are able
to differentially price between both types of travelers.
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provides (patent rights). The regulatory monopolist can set these
prices in such a way that they best enable it to fulfill its legal and
regulatory purposes. And in some situations, an optimal
regulatory price structure will involve differential prices.
Moreover, the three prerequisites for price discrimination—
market power, the ability to distinguish users based on their
willingness to pay, and the ability to prevent arbitrage—are often
readily met in the regulatory monopoly context.68 First, as noted,
a regulatory monopoly has market power.69 Indeed, as the single
locus of authority in a regulatory context, it often has unitary
power to set fees that regulated entities must pay.
Second, regulatory monopolies can often differentiate among
users based on their willingness to pay for a particular good,
often through interaction with the entities they regulate. To
illustrate, consider the Securities and Exchange Commission
(SEC). The SEC has a great deal of information on the public
companies it regulates—indeed, it requires these companies to
disclose, on a regular basis, detailed information on their
operations to the SEC and the public.70 If a company misbehaves,
the SEC can use this information to impose a fine.71 Here, the
focus is not so much on a company’s willingness to pay as much
as its ability to pay. If a company is able to pay more, the SEC can
propose a higher fine to fulfill its regulatory purpose of deterring
actors from engaging in malfeasance again.72 Hence, the SEC can use

68. See Fisher, supra note 8, at 3–4 (discussing the three prerequisites for
price discrimination).
69. See Abramowicz & Duffy, supra note 4, at 1545 (describing the PTO as
a “complete monopoly”).
70. See 15 U.S.C. § 78m(a) (2012) (mandating disclosure of certain
information in periodic reports filed with the SEC); see also Filings and Forms,
SEC. & EXCH. COMM’N, https://www.sec.gov/edgar.shtml#.U39gRqnZfww (last
visited Sept. 24, 2014) (describing the various forms the SEC requires) (on file
with the Washington and Lee Law Review).
71. See Edward Rock, Securities Regulation as a Lobster Trap: A Credible
Commitment Theory of Mandatory Disclosure, 23 CARDOZO L. REV. 675, 702–03
(2002) (noting that companies can opt-out of SEC disclosure requirements by
remaining a private company).
72. See id. (arguing that the SEC’s history of strictly enforcing disclosure
requirements contributes to its ability to prevent corporate impropriety).
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information on the actors it regulates to tailor the fines it charges
them.73
Finally, preventing arbitrage between users is often
relatively easy for regulatory monopolies. This is because there
is generally no liquid market for the approval being given by
the regulatory monopoly. For example, consider regulatory
approval by the FDA for a new drug. A company cannot
transfer approval of Drug A to another company that is seeking
approval of Drug B. Rather, that company must obtain its own,
individualized approval from the FDA. This works because the
“product” being sold by the FDA is sui generis—there is no way
to transfer regulatory approval from one product to another.
Accordingly, issues with arbitrage are generally not as
problematic for regulatory monopolists.74
III. The Promise of Differential Pricing in the Market for Patents
A. The Pricing of Patents
To see the potential benefits of differential patent pricing,
one must first understand how the PTO currently prices patents.
Accordingly, this subpart provides a brief overview of the patent
granting process and the fees the PTO charges applicants and
patentees to fund its operations.
As noted throughout this Article, the PTO is the sole
government institution in the United States in charge of granting
patents.75 To get a patent, an inventor must file a patent
73. See, e.g., id. at 703 (discussing the SEC’s monopoly over criminal
sanctions in securities cases and the functions of the SEC disclosure systems).
74. Arbitrage may be possible for regulatory products that have a
secondary market, such as taxicab medallions or liquor licenses. See, e.g.,
Michael M. Grynbaum, 2 Taxi Medallions Sell for $1 Million Each, N.Y. TIMES
(Oct. 20, 2011), http://cityroom.blogs.nytimes.com/2011/10/20/2-taxi-medallionssell-for-1-million-each/ (last visited Sept. 24, 2014) (detailing one secondary sale
of taxi medallions in New York City) (on file with the Washington and Lee Law
Review).
75. The PTO grants three kinds of patents—utility, design, and plant.
Design patents cover new and original ornamental designs in articles of
manufacture, and plant patents cover certain types of invented or discovered
plant species. See 35 U.S.C. §§ 171, 161. The colloquial use of the term “patent”
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application with the PTO.76 The PTO will then review the
application and determine whether the described invention
satisfies the statutory criteria for patentability—primarily,
whether the claimed invention is useful,77 novel,78 and
nonobvious to a person having ordinary skill in the relevant art.79
If the PTO determines an application meets the necessary
criteria,80 it will send the applicant a notice of allowance, and
refers to utility patents, which cover all other patentable inventions. Utility
patents make up over 90% of all patent filings and grants, and the vast majority
of the PTO’s resources are spent on utility patent examination. U.S. Patent
Statistics Chart, supra note 23. So the focus of this paper is on utility patents.
76. An applicant may file an original patent application with the PTO, or
they may file an application overseas at a foreign patent office under the Patent
Cooperation Treaty, and subsequently file a “national stage” application with
the PTO. See 35 U.S.C. §§ 111, 371 (2012). Regardless where the original
application is filed, however, the PTO is the entity that determines whether a
given invention will receive patent protection in the United States.
77. See id. § 101 (requiring patentable invention to be “new and useful”).
This patentability requirement is referred to as the “utility” requirement. It is
generally easily met by most applicants so long as the invention provides some
kind of de minimis benefit and is at least theoretically capable of being used.
78. See id. § 102 (describing the “novelty” condition of patentability). A
claimed invention lacks novelty if it was described in an earlier-filed patent or
published patent application that names another inventor, or if it was
“patented, described in a printed publication, or in public use, on sale or
otherwise available to the public before the effective filing date of the claimed
invention.” Id. § 102(a)(1)–(2). There are some exceptions, such as if the inventor
himself makes the public disclosure less than one year prior to seeking patent
protection. Id. § 102(b)(1)(A).
79. Id. § 103. Nonobviousness is typically the most difficult hurdle for a
patent applicant to clear. See Jeanne C. Fromer, The Layers of Obviousness in
Patent Law, 22 HARV. J.L. & TECH. 75, 76 (2008) (stating that the nonobvious
element “requires that an invention represent a significant technological or
scientific breakthrough compared to what is already known or doable”). Indeed,
it is often referred to as the “ultimate condition of patentability.” Id. at 75 (citing
NONOBVIOUSNESS—THE ULTIMATE CONDITION OF PATENTABILITY (John F.
Witherspoon ed., 1980)).
80. Other patentability requirements include the enablement requirement,
which requires the patent application to enable one having ordinary skill in the
relevant art to make and use the claimed invention, and the written description
requirement, which requires that the specification portion of the patent
application adequately describe the invention. 35 U.S.C. § 112(a). The Federal
Circuit has found the written description and enablement requirements to be
separate and distinct from one another. See In re Curtis, 354 F.3d 1347, 1357
(Fed. Cir. 2004) (“We interpret 35 U.S.C. §112, ¶1 to require a written
description requirement separate and apart from the enablement
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upon payment of an issue fee by the applicant, the patent
application will turn into a valid and enforceable patent.81
Although there is significant variation across industry categories
and over time, about 50% of filed patent applications eventually
issue.82
The PTO’s chief patent-related expenses are the costs it
incurs in reviewing patent applications.83 Unlike other
government institutions, the PTO must rely on user fees to pay
these costs.84 In other words, the cost of examining patent
applications is borne by the applicants who seek review by the
PTO and by the patentees who have already received patent
protection. If the PTO does not receive sufficient funds from its
users to cover its operations for a particular year, then it suffers a
budgetary shortfall. If it receives an excess of funds, those funds
are deposited in a Patent and Trademark Fee Reserve Fund, a
new creation of the America Invents Act of 2011.85 These fees are
available to the PTO so long as Congress includes them in the
PTO’s annual appropriations bill.86
requirement.”).
81. See 35 U.S.C. § 151 (describing the issuance of a patent).
82. See U.S. PATENT & TRADEMARK OFFICE, PERFORMANCE AND
ACCOUNTABILITY REPORT FISCAL YEAR 2012, at 26 fig. 11 (2012)
http://www.uspto.gov/about/stratplan/ar/USPTOFY2012PAR.pdf
[hereinafter
2012 PTO REPORT] (showing a 12-month rolling average allowance rate between
41% and 52% in 2009–2012).
83. See id. at 74 (showing that PTO personnel costs (primarily from patent
examination review) are its most significant expense). As its name suggests, the
PTO also processes trademark applications, though this forms a much smaller
part of the organization. To illustrate, at the end of fiscal year 2012, the USPTO
had a total of 11,531 employees, 7,935 of which were patent examiners and only
386 of which were trademark attorneys. Id. at 10. 89.8% of fiscal year 2012
revenue came from the patent sector, while 10.2% came from trademarks. Id. at
72.
84. See id. at 9 (noting that the PTO became fully dependent on user fees in
1990 as part of the Omnibus Budget Reconciliation Act (OBRA), Pub. L. No.
101-508, 104 Stat. 1388 (1990)).
85. See Leahy–Smith America Invents Act, Pub. L. 112-29, § 22, 125 Stat.
284 (2011) (codified at 35 U.S.C. § 42(c)(2) (2012)).
86. See 35 U.S.C. § 42(e) (2012) (requiring the PTO to submit to Congress
annually certain information for appropriation purposes). In the past, excess
funds received by the PTO were often siphoned away by Congress in a process
known as fee diversion. See Frakes & Wasserman, PTO’s Granting Patterns,
supra note 11, at 76–78 (discussing the fee diversion process). The PTO s e e m s
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The fees the PTO charges applicants fall into three main
categories. First, the PTO charges filing, search, and examination
fees (collectively called “front-end fees”), which are due when the
patent application is filed.87 These fees are paid by all patent
applicants even if their patent never issues. Front-end fees are
supposed to pay for the patent examination process—the process
by which the PTO determines whether an application satisfies
the requirements of patentability.88 However, as the PTO
explains, to foster innovation and “encourage innovators to take
advantage of patent protection, the Office sets basic ‘front-end’
fees . . . below the actual cost of carrying out these activities.”89
The PTO increased front-end fees for utility patents from $1,260
to $1,600 in 2013 when it exercised for the first time its new feesetting authority under the America Invents Act. But these
amounts are still below its $3,569 estimated cost of reviewing a
utility patent application in 2011.90 So application fees cover less
than half the cost of examining a patent application, and the PTO
must rely on other fees to cover this shortfall.
These other fees are of two varieties. The first are issue fees,
which are fees an applicant must pay the PTO before an approved
patent application actually issues and becomes enforceable.91
Issue fees are paid only for patent applications that will actually
issue (i.e., applications the PTO decides meet the legal standard
of patentability) and not for patent applications that were filed
but never issue.92 Even though the PTO decreased issue fees from
t o believe that the creation of the Patent and Trademark Fee Reserve Fund
“mitigates the issue of fee diversion” and indicates that the PTO “will continue
to work closely with Congress to ensure full access to fees paid by patent
applicants and patentees, consistent with the AIA.” Setting and Adjusting
Patent Fees, 78 Fed. Reg. 4211, 4255 (Jan. 18, 2013).
87. See 35 U.S.C. § 41 (explaining the patent fee structure).
88. See id. § 131 (addressing the examination process for patent
applications).
89. Setting and Adjusting Patent Fees, 78 Fed. Reg. 4211, 4216 (Jan. 18,
2013).
90. Id. at 4227. In fiscal year 2012, 30.9% of total patent revenue came
from front-end fees. 2012 PTO REPORT, supra note 82, at 72–73.
91. See 35 U.S.C. § 41 (describing issue fees).
92. See id. § 151 (“Upon payment of [the issue fee] the patent may
issue . . . .”).

REGULATORY MONOPOLY

1881

$1,770 to $960 in 2013, they still exceed the PTO’s estimated cost
of $257 for actually issuing the patent.93 Accordingly, patent issue
fees are priced well above the cost of patent issuance.
Patentees must also pay maintenance fees, which are
payments a patentee must make to the PTO at certain intervals
during the patent term to keep the patent from lapsing.94 For all
patents issued since 1981, the PTO has required three
maintenance
fee
payments,
due
at
three-and-a-half,
seven-and-a-half, and eleven-and-a-half years after patent
issuance.95 If a patentee elects not to pay a maintenance fee, then
the underlying patent will lapse—it will not be a valid patent and
will no longer be enforceable.96 Put differently, failure to pay
maintenance fees in effect shortens patent term such that it ends
early.
Maintaining a patent costs the PTO nothing; nonetheless,
three-and-a-half,
seven-and-a-half,
and
eleven-and-a-half
maintenance fees are $1,600, $3,600, and $7,400, respectively (up
from $1,150, $2,900 and $4,810, respectively, in 2013).97 So the
PTO prices maintenance fees significantly above cost to subsidize
the below-cost pricing of front-end application fees.98
Above-cost pricing of issue fees and maintenance fees also
allows the PTO to give discounts to certain “smaller” inventors.
As noted, applicants and patentees pay the same amount of fees
regardless of the type of underlying invention, or the industrial
category into which the invention fits. But the PTO does lower
fees depending on the size of the patent assignee, which is the
party that owns the patent right. In particular, if a patent
assignee is an individual, or a small business or nonprofit
93. Setting and Adjusting Patent Fees, 78 Fed. Reg. 4211, 4236 (Jan. 18,
2013). In fiscal year 2012, $463.3 million (21.3% of total patent revenue) came
from issue fees. 2012 PTO REPORT, supra note 82, at 72–73.
94. See 35 U.S.C. § 41 (2012) (describing maintenance fees).
95. See id. § 41(b)(1)–(2) (stating that patentees may receive a six-month
grace period to pay maintenance fees, conditioned on payment of surcharges).
96. See id. (describing the effect of failure to pay maintenance fees).
97. Setting and Adjusting Patent Fees, 78 Fed. Reg. 4211, 4236 (Jan. 18,
2013).
98. In fiscal year 2012, $697.9 million (32.1% of total patent revenues)
came from maintenance fees. 2012 PTO REPORT, supra note 82, at 72–73.
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organization that is small enough to meet certain criteria, then
the assignee might qualify for “small-entity” status.99 Small
entities pay one-half of the normal PTO fees as mandated by
Congress.100 About 20% of patents issued between 2008 and 2012
were issued to small entities.101
Additionally, as part of the recently-passed America Invents
Act, Congress created a “micro-entity” status, which consists of
two categories of inventors. First, it includes small-entity
inventors who have filed no more than four previous U.S. patent
applications and have gross income for the previous year that
does not exceed three times the median household income.102
Second, it includes inventors who are employed by an institution
of higher education and whose patent application is assigned,
granted, licensed, or otherwise conveyed to that institution.103
The AIA mandates that micro-entities pay only one-quarter of the
standard PTO fees.104
B. The Effect of Patent Prices on Innovation
One of the primary goals of the PTO is to promote
innovation.105 To the extent we believe patents incentivize
99. See 37 C.F.R. § 1.27 (2013) (defining “small entity”).
100. See 35 U.S.C. § 41(h) (2012) (“[F]ees charged shall be reduced by 50
percent with respect to their application to any small business concern . . . .”).
101. See 2012 PTO REPORT, supra note 82, at 185 tbl.11 (showing the percent
of utility patents issued to small entities was between 19.76% and 20.87% in
2008–2012).
102. See 35 U.S.C. § 123(a)–(c) (defining “micro-entity”). The provision also
requires that the inventor not assign, license, or otherwise give an ownership
stake in the patent application (or be in a contract requiring any of these
actions) to any entity that exceeds the income limitation. Id. § 123(c).
103. See id. § 123(d) (providing that this obligation could be met if the
employee of the higher education institution is under contract to assign, grant,
license, or convey the application to the institution).
104. See Leahy–Smith America Invents Act, Pub. L. 112-29, § 10(b), 125
Stat. 284 (2011) (reducing fees “by 75 percent with respect to the application of
such fees to entity”).
105. See 2012 PTO REPORT, supra note 82, at 8 (noting that the PTO’s
mission is: “Fostering innovation, competitiveness and economic growth,
domestically and abroad to deliver high quality and timely examination of
patent and trademark applications, guiding domestic and international
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innovation―something most commentators take for granted and
the PTO certainly believes―improving access to the patent
system should spur inventive activity.106
One way the PTO could improve access would be to lower the
fees it charges applicants and patentees. These could be front-end
fees—filing, search, and examination fees paid when an applicant
files her application—or back-end fees—issue fees paid when the
patent issues or periodic maintenance fees paid to keep the
patent in force after issuance. All else being equal, lowering any
of these fees would lower the cost of obtaining and maintaining a
patent. On the margin, this should increase patenting activity
and spur innovation.
Of course, such a change might cause the PTO to lose
revenue. For example, if the increase in patent applications filed
under the reduced fee regime is not sufficient to make up for the
revenue lost because fees are lower, then the PTO’s revenue
would decrease. To give a simple numerical example, suppose
that 1 million patent applications would be filed if the cost of
filing and obtaining a patent were $5,000, and 1.2 million
applications would be filed if this cost were lowered to $4,000.
Although the number of applications filed increased from 1
million to 1.2 million (20% increase) in response to the decrease
in cost from $5,000 to $4,000 (20% decrease), the total revenue
has decreased from $5 billion to $4.8 billion. So the patent office
would lose $200 million in revenue even though the number of
applications filed has increased because this increase was not
sufficient to make up for the reduced fees.
This possibility of lost revenue might create a serious
problem because the PTO depends entirely on user fees for

intellectual property policy, and delivering intellectual property information and
education worldwide, with a highly skilled, diverse workforce”). The PTO also
notes it is “uniquely situated to support the accomplishment of the Department
[of Commerce]’s mission to create the conditions for economic growth and
opportunity by promoting innovation, entrepreneurship, competitiveness, and
stewardship.” Id. (emphasis in original).
106. See Setting and Adjusting Patent Fees, 78 Fed. Reg. 4211, 4214 (Jan.
18, 2013) (explaining how the patent laws operate to spur innovation). But see
Boldrin & Levine, supra note 13, at 3 (arguing there is no evidence that patents
increase productivity).
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funding.107 So ideally, any change in fees should strive to be at
least revenue-neutral. In particular, the goal should be to
structure fees such that the PTO balances its budget but
innovation is maximally incentivized.
How could this be accomplished? In a recent rule, the PTO
described its strategy:
The Office’s current fee structure includes statutory fees (set
by Congress) that provide lower, below cost fees on the front
end of the patent process (e.g., filing, searching, and
examination fees), which are in turn balanced out by higher,
above cost fees on the back end (i.e., issue and maintenance
fees). This balance enables the Office to provide lower costs to
enter the patent system, making it easier for inventors to
pursue patents for their innovations, and these lower frontend fees are off-set by higher back-end fees. Congress set this
balance when it established the existing statutory fee
structure, and the Office continues to follow this model with
the fee structure in this final rule, because a key policy
consideration is to foster innovation by facilitating access to
the patent system.108

So the key is to subsidize lower front-end application fees with
higher back-end issue fees and maintenance fees.
Why might this fee structure promote innovation? The
answer to this question finds support in both neoclassical and
behavioral economics. Traditional economics teaches us people
discount events that happen in the future.109 Suppose someone is
asked whether they prefer to receive one dollar today versus one
dollar tomorrow. Most people would prefer to receive the dollar
today, not merely because of inflation but because an individual
can use that dollar today to buy something.110 In economic terms,
107. See, e.g., Masur, supra note 23, at 499 (noting the importance of user
fees); Frakes & Wasserman, PTO’s Granting Patterns, supra note 11, at 76
(same).
108. Setting and Adjusting Patent Fees, 78 Fed. Reg. 4211, 4214 (Jan. 18,
2013).
109. See, e.g., Russell B. Korobkin & Thomas S. Ulen, Law and Behavioral
Economics: Removing the Rationality Assumption from Law and Economics, 88
CAL. L. REV. 1051, 1119 (2000) (“Because of the time value of money, rational
actors will discount future income.”).
110. See id. (“[T]o give up a dollar today, [rational actors] will demand
something more than a dollar tomorrow.”).

REGULATORY MONOPOLY

1885

whatever activity the individual could use that dollar for today is
the opportunity cost of receiving it tomorrow instead.111
Behavioral economics adds to this discussion by introducing
something known as hyperbolic discounting, which describes how
people are often inconsistent in discounting over time.112 In
particular, many people are “present-biased”—their level of
discounting is very steep for events in the near-future but much
less-steep for events later on.113 So discounting can be important
even when dealing with relatively short-run events.
A classic illustration of hyperbolic discounting comes from an
extension to the dollar-today, dollar-tomorrow hypothetical.
Suppose instead the operative questions are whether you would
prefer: (1) a dollar today versus three dollars tomorrow; or (2) a
dollar in one year versus three dollars in one year and one day.
Many people would prefer receiving the dollar today in
hypothetical (1) but the three dollars in hypothetical (2). This is
referred to as time-inconsistent behavior and cannot be explained
by traditional exponential discounting. Rather, one needs
discounting that is very steep at first and then becomes
shallower, which is the essence of hyperbolic discounting.114
Despite differences in the neoclassical and behavioral
approaches, both point to the same conclusion: inventors’
behavior will be more influenced by front-end rather than backend patent fees. In other words, discounting (whether hyperbolic
or not) suggests that changes in front-end fees will affect
potential patent applicants’ behavior more than similar changes
to back-end fees.

111. See Rafael I. Pardo, Reconceptualizing Present-Value Analysis in
Consumer Bankruptcy, 68 WASH. & LEE L. REV. 113, 131 (2011) (noting that the
time value of money reflects opportunity cost as well as any expected inflation).
112. See Korobkin & Ulen, supra note 109, at 1120 (indicating that,
according to behavioral science literature, personal discount rates tend to
decrease more as the date of an expected reward is delayed).
113. See id. (noting that this principle leads people to consume more in the
present even if they previously planned to consume less).
114. See R.H. Thaler, Some Empirical Evidence on Dynamic Inconsistency, 8
ECON. LETTERS 201, 202 (1981) (discussing work by R. Strotz, Myopia and
Inconsistency in Dynamic Utility Maximization, 23 REV. ECON. STUD. 165, 165–
80 (1955)).
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This is why the PTO’s basic pricing strategy makes sense.
Front-end fees are most salient to potential inventors; hence,
reducing them encourages patenting behavior and (hopefully)
innovation.115 On the other hand, applicants are less affected by
changes to back-end fees, so these fees can be increased to recover
lost revenue. In economic terms, potential inventors’ demand for
patent protection is relatively elastic with respect to front-end
fees (i.e., small changes in these fees will have a relatively large
effect on patenting behavior) but is relatively inelastic with
respect to back-end fees (i.e., small changes in these fees will
have a relatively small effect on patenting behavior).116
C. Third-Degree Price Discrimination in the Market for Patents
The previous subpart described why the current fee
structure, which charges patentees more on back-end versus
front-end fees, arguably promotes innovation. But this fee
structure is not optimal; indeed, this Article explains how it could
be improved. In particular, the PTO could increase its back-end
revenues by engaging in third-degree price discrimination, where
it implements differential pricing of issue fees, maintenance fees,
or both across industry categories. The variation in fees across
industries would stem from industry-level differences in
patentees’ willingness to pay to obtain and maintain patent
protection. As discussed later, the PTO could use the increased
revenue it receives from differential pricing to lower front-end
fees or to improve the services it provides to patent applicants,
such as by hiring additional examiners to reduce application
backlog.
115. See U.S. PATENT & TRADEMARK OFFICE, USPTO SECTION 10 FEE
SETTING—DESCRIPTION
OF
ELASTICITY
ESTIMATES
10–12
(2013),
http://www.uspto.gov/aia_implementation/aia_section_10_elasticity_supplement
.pdf [hereinafter ELASTICITY ESTIMATES] (describing USPTO’s estimates of price
elasticity of demand for changes in user fees).
116. See id. at 1 (explaining that price elasticity of demand measures how
sensitive consumers—here, patent applicants—are to changes in price—here,
user fees); see also Gaetan de Rassenfosse & Bruno van Pottelsberghe de la
Potterie, On the Price Elasticity of Demand for Patents, 74 OXFORD BUL. OF
ECON. AND STAT. 58 (2012) (analyzing effect of patent fees on patent demand).
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To understand how third-degree price discrimination could
help the PTO achieve its regulatory goals,117 recall that this form
of differential pricing involves partitioning a market into
segments and charging people within each segment the same
price.118 Often this is done for identifiable groups that are less
likely to pay for a good; canonical examples include discounts for
students or seniors.119 Third-degree price discrimination allows a
monopolist to charge more to people in groups that, on average,
are willing to pay more for a particular good and to charge less to
people in groups that, on average, are willing to pay less. The
monopolist can therefore charge the former group a higher price
while not pricing the latter group out of the market.120
In the context of patents, the PTO could use third-degree
price discrimination to charge different prices to applicants and
patentees in different industries depending on their willingness
to pay for patent protection.121 For example, if pharmaceutical
117. Theoretically, the PTO could also engage in first-degree price
discrimination, in which it customizes fees for each applicant such that
individuals are charged exactly the amount they are willing to pay for patent
protection. In reality, the PTO could not engage in this form of differential
pricing because it would lack individualized information on patentees’
willingness to pay. First-degree price discrimination is more of a theoretical
benchmark than something achievable in practice. See Gifford & Kudrle, supra
note 8, at 1241 (noting that first-degree discrimination occurs only in rare
circumstances).
118. See Fisher, supra note 8, at 4 (“In third-degree price discrimination, the
seller does not know the purchasing power of the individual buyers, but is able
to separate them into individual groups that correspond roughly to their wealth
or eagerness.”).
119. See id. (explaining the common practice of third-degree price
discrimination to create student and senior discounts).
120. See Posner, supra note 50, at 570 (noting that price discrimination
helps monopolists maximize profits).
121. The PTO already engages in a limited form of third-degree price
discrimination through its use of small-entity and micro-entity status. See supra
notes 99–104 and accompanying text (discussing the requirements of smallentity and micro-entity status). Patent applicants and patentees who qualify as
“small entities” pay one-half the regular PTO fees; individuals who qualify as
“micro-entities” pay one-quarter the regular fees. Id. It is reasonable to assume
that given their small size, these individuals have a lower willingness or ability
to pay PTO fees than other patent applicants. Accordingly, by charging these
individuals less money, the PTO is, on the margin, allowing some small entities
or micro-entities to enter the market for patents when they would otherwise be
priced out if they did not receive any discounts.
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patentees care more about patent protection than mechanical
patentees, the PTO could charge the former higher maintenance
fees than the latter. Because the pharmaceutical patentees care
more about patent protection, they will be willing to pay more,
hence enabling the PTO to increase its revenues.
Applying the general discussion from Part II.C.1 to the
present context, we see that, to implement third-degree price
discrimination across industries, the PTO must satisfy three
prerequisites: (1) it must have market power; (2) it must have
industry-level information on users’ willingness to pay; and (3) it
must be able to prevent arbitrage between users.122 Requirements
(1) and (3) are easily met here. First, the PTO has a regulatory
monopoly over the granting of patent rights in the United
States.123 Moreover, to obtain a patent and keep it in force, an
applicant must pay whatever fees the PTO charges.124
Additionally, preventing patentees from arbitraging patent
rights should not be a major concern for the PTO. This is
primarily because patent rights are not fungible, and approval
and continued validity of patents are not transferable rights. For
122. See supra Part II.C.1 (explaining the prerequisites for third-degree
price discrimination).
123. See 35 U.S.C. § 2 (2012) (granting the PTO sole authority to issue
patents and to register trademarks).
124. See id. § 41 (implementing fees for patent applications). Although the
PTO has a regulatory monopoly over the granting of patent rights, trade secret
protection is a substitute legal right that some inventors might pursue. See
Mark A. Lemley, Intellectual Property and Shrinkwrap Licenses, 68 S. CAL. L.
REV. 1239, 1268 (1995) (noting that trade secret law is a species of state common
law). Trade secret law prevents the misappropriation of private information by
competitors or others. See Kewanee Oil Co. v. Bicron Corp., 416 U.S. 470, 474–
75 (1974) (stating that a trade secret may consist of any formula, device, or
compilation of information that gives a business an advantage over competitors
who do not possess the trade secret). Of course, a trade secret works only if the
product or service at issue cannot easily be reverse-engineered—if a competitor
can buy the product and figure out the inventive or novel aspect of its design,
then trade secret law provides no protection against copying or replication. A
valid patent, on the other hand, allows an inventor to exclude his competitors
from making, using, or selling the invention, even if the competitor had been
unaware of the existence of the patent prior to being sued for infringement. See
id. at 474 (holding that federal patent law does not preempt state trade secret
laws). But see 35 U.S.C. § 273 (introducing, as part of the America Invents Act of
2011, a limited defense to infringement based on prior commercial use).
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example, an individual who receives approval of patent
application A cannot transfer that approval to a different patent
application B. Each patent application is evaluated
independently on its own merits.125 Hence, the PTO can
differentially price patents without fear that applicants can get
around this pricing by selling approved patent rights to one
another.
The remaining requirement is the trickiest one—obtaining
industry-level information on users’ willingness to pay. However,
my recent empirical research (discussed in more detail in Part IV,
infra) sheds light on this precise topic. In particular, my research
uses actual patent applicant behavior to generate an objective,
cross-industry measure of how much applicants care about patent
protection. The PTO could use this information to restructure its
patent fees so that patentees are charged based on how much
they care about patent protection.
While the PTO could use differential pricing for any of the
fees it charges, maintenance fees—particularly the final
maintenance fee due at eleven-and-a-half years—might be the
best one to price differentially. There are at least a couple reasons
for this. First, to the extent we are concerned that higher fees
might reduce incentives to innovate, it would be best to raise the
fees charged latest in the patent lifecycle. Applicants are likely to
discount these fees the most, and it seems unlikely that a modest
increase in these fees would greatly affect their decision to
engage in inventive activity.
Second, maintenance fees are relatively low compared to the
revenues that a successful invention likely generates.126 Current
maintenance fees at three-and-a-half, seven-and-a-half and
eleven-and-a-half years are $1,600, $3,600 and $7,400,
respectively.127 Although there might be uncertainty when a

125. See 35 U.S.C. § 131 (explaining the examination process of a patent
application).
126. See Setting and Adjusting Patent Fees, 78 Fed. Reg. 4211, 4237 (Jan.
18, 2013) (listing current maintenance fees).
127. See id. at 4236 (increasing fees most recently in 2013, from $1,150,
$2,900, and $4,810, respectively). In a follow-up empirical paper, I am
researching whether patentees and patent applicants changed their behavior in

1890

71 WASH. & LEE L. REV. 1855 (2014)

patent issues whether it will be successfully commercialized, that
uncertainty should be reduced or eliminated by the time the last
maintenance fee is due. And because the present value (at the
time of maintenance fee payment) of a commercially successful
product is likely to exceed $7,400, it is unlikely that a modest
increase in maintenance fees would affect potential inventors’ ex
ante decisions whether to innovate.
D. Differential Pricing to Incentivize Innovation
The previous subpart described how the PTO could
implement differential patent pricing across industry categories,
and how this would increase PTO revenues. But how might the
PTO use these additional revenues to incentivize innovation or
improve the patenting process?
First, the PTO could encourage innovative activity by using
the additional funds received from differential pricing of back-end
fees to reduce front-end fees, which are more likely to be salient
in affecting inventors’ decisions.128 As discussed previously, to the
extent patents incentivize innovation, lower front-end fees are
likely to promote inventive activity.129 Differentially higher back-

response to this increase. I am also using the increase as a natural experiment
to reveal information about relative patent values across industries.
128. See supra notes 107–116 and accompanying text (describing price
elasticity as it applies to patent fees).
129. Jonathan Masur has argued that the relatively high cost of patent
applications could be useful to screen out low-quality patent applications. See
Jonathan S. Masur, Costly Screens and Patent Examination, 2 J. LEGAL
ANALYSIS 687, 711–12 (2012) (explaining that a costly patent screening process
prevents inefficiency and the over-granting of patents); cf. Ian Ayres & Paul
Klemperer, Limiting Patentees’ Market Power Without Reducing Innovation
Incentives: The Perverse Benefits of Uncertainty and Non-Injunctive Remedies,
97 MICH. L. REV. 985, 986–87 (1999) (discussing how uncertainty in patent
rights can be socially optimal by increasing social welfare and only weakly
reducing incentives to invent generated by patent monopoly rights). To the
extent one is concerned about too many junk patent applications, the PTO might
instead consider lowering issue fees rather than front-end fees. This would only
benefit those individuals whose patent applications actually meet the standards
of patentability, thereby incentivizing innovation only for applicants who believe
their patent will actually issue.

REGULATORY MONOPOLY

1891

end fees, on the other hand, are likely to have little negative
effect on inventive activity.
Put differently, one can view differential pricing combined
with revenue neutrality as a type of transfer payment. The PTO
can charge those who derive more benefit from the patent system
(i.e., those who care more about patent protection) a higher fee. It
can transfer this additional revenue to individuals who care less
about patent protection by reducing their fees. The groups that
care more about patent protection are unlikely to change their
behavior significantly as their demand for patent protection is
inelastic. The groups that care less about patent protection, on
the other hand, might increase innovative activity because the
price of patenting has decreased for them.130
Alternatively, the extra revenue obtained from differential
pricing could be used more directly to improve the patent system.
Legal scholars often talk of a patent system in crisis.131 While
patent trolls and escalating litigation costs grab headlines, a
more prosaic concern is the increased delay and backlog of
applications at the PTO.132 Over the past fifteen years, the PTO
has taken longer and longer to determine whether an applicant is
deserving of a patent.133

130. See ELASTICITY ESTIMATES, supra note 115, at 2–4 (discussing the
elasticity of demand for patents).
131. See, e.g., DAN L. BURK & MARK A. LEMLEY, THE PATENT CRISIS AND HOW
THE COURTS CAN SOLVE IT (2009) (describing the current state of affairs as a
“patent crisis”); JAMES BESSEN & MICHAEL J. MEURER, PATENT FAILURE: HOW
JUDGES, BUREAUCRATS, AND LAWYERS PUT INNOVATORS AT RISK (2008) (same);
Masur, supra note 23, at 477 (same). But see John M. Golden, Proliferating
Patents and Patent Law’s Cost Disease, 51 HOUS. L. REV. 455, 457 (2013)
(suggesting claims of a patent “crisis” might be overstated).
132. See Dennis Crouch, Patent Pendency Time Series and Why Care About
Prosecution Delays, PATENTLY-O (Sept. 10, 2012), http://www.patentlyo.com/
patent/2012/09/patent-pendency-time-series-and-why-care-about-prosecutiondelays.html (last visited Sept. 24, 2014) (describing the growing issue of
increased patent pendency) (on file with the Washington and Lee Law Review).
133. See id. (showing that median prosecution pendency for U.S. utility
patents has increased from about 2 years in 1999 to about 3.25 years in 2012,
with a peak over 3.6 years in 2009). Patent application pendency appears to
have decreased a bit in the past few years, likely in part because the PTO has
hired thousands of new patent examiners and also due to the 2007–2009
recession and persisting weakness in the U.S. economy. Id.
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Recent research suggests the PTO’s reliance on fees from
patent applicants and patentees to fund its operations might be
straining the organization financially, which in turn might cause
this backlog. In particular, the PTO might be deferring patent
applications that take longer to examine in favor of ones that
take less time to manage its workload and maximize the fees it
gathers.134
Differential pricing has the potential to improve the PTO’s
financial standing and hence alleviate the backlog problem. For
example, increased revenues obtained from differential pricing
might be used to hire more examiners in technology groups with
insufficient resources. By doing this, the workload of examiners
in these areas might be alleviated, and delays that applicants
face might be reduced. This reduction in PTO delay increases the
value of patent protection to applicants.135
Moreover, this sort of reform could improve the quality of the
PTO’s review process. If examiner workload were lessened, then
examiners could devote more time to review each application they
are assigned. More time to review applications could in turn
reduce the granting of “bad patents”—patents the PTO should
never have granted because they do not meet the statutory
standards of patentability.136 A reduction in bad patents would in
turn benefit society as a whole, as the costs these patents impose
would be reduced.137
134. See Frakes & Wasserman, Failed Promise, supra note 11, at 10–12
(noting how the PTO operates under budget constraints).
135. See id. at 5 (explaining costs associated with examination delay). It might
be preferable to use additional revenue from differential pricing to streamline
PTO processes rather than to lower front-end fees, as recent research suggests
higher back-end fees might distort PTO examination practices or granting
behavior. See generally id.; Frakes & Wasserman, PTO’s Granting Patterns, supra
note 11.
136. See, e.g., Jay P. Kesan & Andres A. Gallo, Why “Bad” Patents Survive in
the Market and How Should We Change?—The Private and Social Costs of
Patents, 55 EMORY L.J. 61, 76 (2006) (discussing PTO’s incentives to “grant
patents without being unduly concerned about the quality of the examination
process”).
137. See Mark Lemley, Doug Lichtman & Bhaven Sampat, What to Do About Bad
Patents?, 28 REG. 10, 10–11 (2005) (describing how an examiner spends on average
only eighteen hours reviewing each patent application and how more PTO funding
might alleviate the bad patents problem). But see Keson & Gallo, supra note 136 (describing
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E. Differential Pricing to Limit Patent Term
Our discussion thus far has focused on increasing PTO
revenues through the use of differential patent pricing on backend fees, and then using those revenues to lower front-end fees or
otherwise improve the patenting process. But differential pricing
could also achieve a more fundamental goal: to create different
effective patent terms for different categories of inventions.
1. The Rationale for Tailoring Term for Different Industries
Scholars have long debated the benefits and costs of patents.
Most agree the primary benefit of patent protection is that it
incentivizes innovation—awarding a patentee a legal monopoly
over his invention allows him to recoup fixed costs incurred in
producing his invention.138 But patents also generate a number of
costs. In addition to the deadweight loss caused by heightened
monopoly pricing, a surfeit of patents increases the risk of
inadvertent infringement and can lead to patent thickets, with
multiple parties having overlapping patent rights.139 Such
thickets make it difficult for new innovators, who must obtain
licenses from multiple patentees.140 Moreover, the proliferation of
patents increases the prevalence of patent litigation, which is
particularly costly in suits involving non-practicing entities (often
pejoratively referred to as “patent trolls”). These entities do not

why much of the money might be wasted on review of useless patent
applications).
138. See, e.g., Burk & Lemley, supra note 14, at 1576 (“Patent law is our
primary policy tool to promote innovation, encourage the development of new
technologies, and increase the fund of human knowledge.”).
139. See Sukhatme & Cramer, supra note 10, at 5 (explaining how patent
thickets impose costs on society); Carl Shapiro, Navigating the Patent Thicket:
Cross Licenses, Patent Pools, and Standard Setting, 1 INNOVATION POL’Y & ECON.
119, 121 (Adam B. Jaffe, Josh Lerner & Scott Stern eds., 2001) (acknowledging
that the current patent system causes concern because of “excessively loose
standards” at the PTO).
140. See Joseph Farrell et al., Standard Setting, Patents, and Holdup, 74
ANTITRUST L.J. 603, 608 (2007) (explaining how “standards hold-up” affects the
patent market by requiring expensive licenses from multiple patentees).
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produce anything but merely acquire patents to sue companies
and extract monopoly rents from them.141
One way in which the patent system balances the costs and
benefits of patents is by limiting their term. This seems
reasonable—we want to use patents to incentivize innovation but
are also cognizant of their social costs, so we give inventors a
monopoly over their inventions for a limited time.142 Ideally,
patent term would be invention-specific, and it would be only as
long as necessary to incentivize invention, as additional term
merely gives a patentee excess monopoly rents and incurs social
costs.143
Of course, this is not how patent term is currently awarded.
Rather, all inventions receive the same baseline patent term
regardless of their underlying industry.144 A new type of LED
receives the same baseline term as a new plastic polymer, a new
cancer drug, a new semiconductor chip, or a new type of garbage
can: twenty years from the date the patent application was
filed.145
Regardless of one’s perspective, it seems unlikely that, in an
ideal world, patent term would be the same across all industry
categories because the costs and benefits of patents vary across
141. See James Bessen et al., The Private and Social Costs of Patent Trolls,
34 REG. 26, 29 (2012) (providing a definition of “patent trolls” and introducing
the problems they cause).
142. See Ayres & Klemperer, supra note 129, at 992 (noting that patentees
have “unchecked monopoly power” during the patent term and then no legally
enforceable market power after the patent expires).
143. See Alan Devlin & Neel U. Sukhatme, Self-Realizing Inventions and the
Utilitarian Foundation of Patent Law, 51 WM. & MARY L. REV. 897, 903 (2009)
(arguing that, in the context of certain business method patents, if an invention
would be produced even if patent protection were unavailable, then it should not
receive patent protection in the first place).
144. See 35 U.S.C. 135 (2012) (describing the uniform term of patents).
145. Id. Congress has passed some industry-specific adjustments to patent
term. See Burk & Lemley, supra note 14, at 1630–31 (noting that Congress has
lengthened the patent term for pharmaceutical patents). Most notably, the Drug
Price Competition and Patent Term Restoration Act of 1984 (Hatch–Waxman
Act) enabled “pioneer drugs” to receive patent term extensions of one-half the
time they spend in the investigational new drug period during FDA review. Pub.
L. No. 98-417, 98 Stat. 1585 (1984). Nonetheless, such ad hoc extensions do not
affect the twenty-year baseline term.
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these categories.146 For example, a patented invention in a fastmoving technological field might be obsolete well before its term
ends. In other fields, however, each additional week of patent
term might translate into millions of dollars in additional sales.147
Still, there are many good reasons for having a uniform
patent term. One might worry about the extent to which politics
or other considerations not related to social welfare affect the
term awarded in certain industries.148 Even without such
concerns, it is very difficult to determine what terms are optimal
for patents in different industries. Answering this question
requires, for example, considering how the following vary across
industries: incentives to invent, rates of technology obsolescence,
presence of regulatory delays, time to commercialize a product,
and patent-generated social welfare costs.149
Nonetheless, it might be possible for these objections to be
overcome. For example, in Part IV, I describe objective measures,
which I derived using empirical methods, of the relative
importance of patent protection across different industries.150
Although I do not intend to suggest these measures are by
themselves dispositive as to what patent term should be—as
146. Laws governing the baseline patent term are almost never changed,
suggesting that term is not updated in response to technological, societal, or
legal changes. Since the Patent Act of 1790, when Congress established a term
of fourteen years from patent issuance, the baseline term for a patent has
changed only three times: in 1836 (increased to twenty-one years from patent
issuance), 1861 (decreased to seventeen years from patent issuance), and 1995
(changed to twenty years from application filing date).
147. The most prominent example in which patent term really seems to
matter is pharmaceuticals, as a drug may not even be salable for years into its
patent term due to the extensive FDA regulatory approval process.
148. See Michael W. Carroll, One Size Does Not Fit All: A Framework for
Tailoring Intellectual Property Rights, 70 OHIO ST. L.J. 1361, 1398 (2009)
(noting that altering a uniform patent term would require industry-wide
consensus, which limits the ability to use patent term to benefit special interest
groups); Michael W. Carroll, One for All: The Problem of Uniformity Cost in
Intellectual Property Law, 55 AM. L. REV. 845, 847 (2006) (describing the
problem of “uniformity cost” in patent law, which stems from its attempt to
apply “a socially costly, uniform solution to problems of differing magnitudes”).
149. See Burk & Lemley, supra note 14, at 1630–38 (providing numerous
reasons against using industry-specific legislation to customize patent term).
150. See infra Part IV (discussing differential pricing and empirical methods
for measuring value of patents across industries).
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noted above, determining industry-specific, optimal terms is
likely to be a complicated, multi-factor inquiry—my research
could nonetheless inform this discussion.151
2. Differentially Raising Maintenance Fees to Limit Term
It is one thing to determine what constitutes an optimal term
in a particular industry; it is another thing to actually implement
it. Assuming policymakers wish to have industry-specific patent
terms, they should use the more nuanced approach to
implementing differential term described in this Article. Namely,
they should use differentially higher maintenance fees to
effectively limit term to the extent they desire.
To illustrate, suppose patentees in a particular industry face
the following maintenance fee schedule: at three-and-a-half,
seven-and-a-half, and eleven-and-a-half years, they must pay
$1,600, $3,600, and $74,000, respectively. The only difference
between these hypothetical maintenance fees and actual current
fees is the eleven-and-a-half year fee, which has been increased
tenfold, from $7,400 to $74,000. As a practical matter, only the
relatively few patentees who value their patent this highly would
be willing to make this hypothetical eleven-and-a-half year
maintenance payment.152 For all other patentees, their patent
would end at eleven-and-a-half years.
This hypothetical demonstrates how maintenance fees could
be used to limit patent term in a controlled fashion. For example,
151. One key is to develop an objective measure of optimal patent term
across industries; that is, a measure that is not subject to manipulation and can
be updated using data. Ben Roin suggests one possible measure is the average
time needed to take an invention to market. He claims this variable is a good
proxy for many factors that play a role in determining optimal patent term. See
Roin, supra note 14 (discussing factors that could help determine optimal patent
term across different industries).
152. One might argue that some patentees would make this payment but
might be capital constrained and unable to do so. Presumably, if such patentees
believe this payment would be worthwhile, they would have access to capital
markets and would be able to borrow the money necessary to make the
payment. Regardless, the basic point holds: Only people who value their patent
more than this amount will renew the patent. That does not necessarily mean
that everyone else who does not renew does not value the patent that highly.
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if we want 50% of patents in a particular industry to expire at a
particular time, we can raise maintenance fees on patents in that
industry to the level at which we expect 50% of patentees to stop
paying. If we want 90% of patents to expire, we can increase fees
even more to achieve this goal. And if we want all patents within
an industry to expire, we can make fees as high as necessary to
ensure this happens. In such a scenario, forward-looking
inventors will no longer assume that patent term is twenty years
from the date of patent application but rather it is the length of
time until the prohibitively high maintenance fee is due.
Put differently, limiting patent term is equivalent to
mandating an infinite maintenance fee at the time one wishes a
patent to expire. Viewed this way, proposals to limit patent term
are essentially limiting cases of the general principle enunciated
here: that is, the PTO can arbitrarily control how many patents
remain in effect in a particular industry via differential patent
pricing.
Such pricing gives policymakers a bevy of ways in which to
limit term. Even if just the current maintenance fee date
schedule is used, one could limit patent term in a particular
industry to: (1) three-and-a-half years from patent issuance;
(2) seven-and-a-half
years
from
patent
issuance;
(3) eleven-and-a-half years from patent issuance; or (4) twenty
years from patent application filing. Moreover, a policymaker
could increase maintenance fees in such a way that not all
patents expire but rather some desired percentage of patents are
not renewed.153
If one wishes to customize patent term across industries,
there are a number of advantages to using differential patent
pricing to achieve this goal rather than simply mandating that
patents in certain industries have a reduced duration. First,
153. David Olson recently suggested that maintenance fees could be
increased based on the number of nonpracticing patents within a patent owner’s
portfolio. The idea is that increased fees will deter nonpracticing entities, often
referred to as patent trolls, from amassing patents. See David S. Olson,
Removing the Troll from the Thicket: The Case for Enhancing Patent
Maintenance Fees in Relation to the Size of a Patent Owner’s Non-Practiced
Patent Portfolio, (B.C. Law Sch. Legal Studies Res. Paper Series No. 303, at 2
2013), available at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2318521
(last visited Sept. 24, 2014) (on file with the Washington and Lee Law Review).
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differential patent pricing enables policymakers to have
heightened flexibility to deal with outlier inventions. Regardless
of the industry at issue, there will likely be unusual inventions
for which additional patent term is crucially important. Instead
of dictating that these inventions have some limited term, the use
of differential patent pricing allows patentees of very valuable
inventions to extend their term as desired.
Second, limiting term for patents in particular industries is a
drastic shift that would require congressional action. This would
seem difficult to achieve in practice as those industries would
likely fight such legislation with full force. Allowing the PTO to
use differential patent pricing to achieve the goal of limiting
patent term might also require congressional action, but it is a
more limited and nuanced step that seems more likely to be
achievable in practice.154
Third, differential patent pricing allows for more dynamic
changes than a scheme that simply limits patent term. For
example, suppose there is a push to limit term for software
patents to eight years from the date of patent issuance. Instead of
limiting patent term for this group of inventions, the PTO could
simply increase the seven-and-a-half year maintenance fee. The
PTO could then monitor how patentee renewal decisions are
affected as well as decisions by prospective inventors regarding
future innovation in this field. If innovation appears to be greatly
harmed by this fee increase, then maintenance fees could be
reduced. If there appears to be no effect on innovation, then the
fees could be increased more.155
Despite these advantages, there are limits to what
differential pricing of maintenance fees can accomplish in terms
of tailoring patent term. If we feel that patent term is insufficient
in certain industries,156 then differential pricing of maintenance
fees would be unable to provide this additional term.
154. See infra Part V for legal analysis of this issue.
155. Introducing cross-industry variation into maintenance fees would also
have the ancillary benefit of generating rich data on the relative importance of
patents across industries. This could be used to perform more research on the
relationship between patents and innovation, which in turn could be used to
improve the patent system.
156. This might be true, for example, with respect to pharmaceuticals, which
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Even so, other forms of differential patent pricing might be
able to handle this situation. For example, while the present
discussion has focused on differential patent pricing of
maintenance fees, the same logic can be applied to other prices in
the patent system. Suppose patent applicants were asked, when
they apply, to choose how much patent term they wished to have.
Some might be willing to pay more to get a longer term. Such a
pricing scheme would essentially be second-degree price
discrimination—the PTO would offer multiple versions of patents
that differ by term. Applicants would reveal their willingness to
pay based on which patent term they choose.157
IV. The Empirical Basis for Differential Patent Pricing
This Article has shown how the PTO could use differential
patent pricing to better achieve one of its core regulatory
purposes—to promote innovation through the U.S. patent system.
In particular, the Article has explained how setting industryspecific maintenance fees might be a good way to implement
differential pricing.158
But an important question remains: even if the PTO can set
differential patent prices, what prices should it set? The present
Part tackles that issue. It begins with an overview of my recent
take a tremendous amount of time and money to develop. See Burk & Lemley,
supra note 14, at 1631 (noting that Congress extended the patent term for
certain pharmaceutical patents). But see Boldrin & Levine, supra note 13, at 13–
14 (arguing for the abolition of pharmaceutical patents).
157. See
supra
Part
II.C.2
(explaining
second-degree
pricing
discrimination). Somewhat relatedly, Mark Lemley and Carl Shapiro have
suggested the PTO could offer applicants two types of patents: ordinary patents
and “super patents,” which undergo a more rigorous examination by the PTO.
See Mark A. Lemley & Carl Shapiro, Probabilistic Patents, 19 J. ECON. PERSP.
75, 85–86 (2005) (stating that such a system would depend on courts giving less
weight to the standard patent than the super patent). A patentee who opts for a
super patent could receive a stronger presumption of validity in subsequent
litigation. Id.; see also Lemley et al., supra note 137, at 10–13 (proposing to have
a “gold-plated” patent review, where applicants who want a stronger
presumption of validity for their patents could opt for a more searching (and
costly) review).
158. See supra Part III.D (arguing that differential pricing could increase
innovation).
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empirical research, which quantifies the extent to which patent
applicants in different industries actually care about patent
term.159 This is important because it shows us the industries in
which patent term matters more, and in particular, the
industries in which patentees might be willing to pay more for
patent protection. After discussing how these empirical estimates
were obtained, the Article explains how they can be translated
into actual differential patent prices.
A. Measuring How Much Patents Matter Across Industries
My empirical research focuses on the following basic
questions: How much do patent applicants and patentees care
about patent term? On average, do applicants in various
industries differ in how much they care about term? And if so,
can we quantify these differences?
Many scholars have speculated on the industries in which
patents are believed to be more or less important. For example,
most scholars believe patent term is particularly important for
pharmaceuticals because it costs a tremendous amount to develop
a drug and receive FDA approval,160 but it costs relatively little to
produce or copy an approved drug.161 Absent patent protection,
most scholars believe there would be little incentive for
companies to produce new drugs because they could not charge
monopoly prices to recoup their fixed costs.162
159. Infra Part IV.A. See generally Sukhatme & Cramer, supra note 10
(studying the effects of The Agreement on Trade-Related Aspects of Intellectual
Property Rights (TRIPS) on the speed of patent prosecution in different
industries).
160. See Joseph A. DiMasi, Ronald W. Hansen & Henry G. Grabowski, The
Price of Innovation: New Estimates of Drug Development Costs, 22 J. HEALTH
ECON. 151, 181 (2003) (estimating that a drug whose research and development
was started in 2001, with approval twelve years later, would have preapproval
capitalized costs of $1.9 billion).
161. See Joan Costa-Font, Alistair McGuire & Nebibe Varol, Price
Regulation and Relative Delays in Generic Drug Adoption, J. HEALTH ECON.
(forthcoming 2014) (manuscript at 1) (noting that generic drugs are cheaper to
produce than branded products) (on file with the Washington and Lee Law
Review).
162. See Emily Michiko Morris, The Myth of Generic Pharmaceutical
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Regarding other industries, scholars have concluded patents
are less important, or even harmful. For example, many scholars
have suggested that patents are unnecessary in the context of
software.163 They assert that new software can be produced at
relatively low fixed cost.164 They also claim most software
becomes obsolete in a short period of time, and hence patent
protection (or at least a long patent term) is unnecessary to
incentivize innovation.165
Much of the conventional wisdom on the relative importance
of patent term might be correct, but it has remained virtually
untested. In other words, while scholars might believe patents
are more or less important to applicants in particular industries,
there has been little empirical evidence to back these assertions.
My empirical work seeks to test the conventional wisdom. To
do this, I take advantage of a natural experiment: the ratification
by the United States of The Agreement on Trade-Related Aspects
of Intellectual Property Rights (TRIPS) on December 8, 1994.166
As discussed below, I use this natural experiment to measure
how much patent applicants care about patent term within
particular industries.167 I also derive a related measure using
Competition Under the Hatch–Waxman Act, 22 FORDHAM INTELL. PROP. MEDIA &
ENT. L.J. 245, 257 (2012) (indicating that, absent patent protection, firms may
be incentivized to copy old drugs rather than develop new drugs). But see
Boldrin & Levine, supra note 13, at 13–14 (pointing out that the first-mover
advantage in drugs might be larger than conventionally realized and that some
combination of public funding and a reward system could replace the patent
system).
163. See, e.g., Pamela Samuelson, Benson Revisited: The Case Against
Patent Protection for Algorithms and Other Computer Program-Related
Inventions, 39 EMORY L.J. 1025, 1025–26 (1990) (questioning the need for
software patents); cf. Devlin & Sukhatme, supra note 143, at 906–10 (arguing
against awarding patent protection for certain business method patents).
164. See Burk & Lemley, supra note 14, at 1687 (“Software inventions tend
to have a quick, cheap, and fairly straightforward post-invention development
cycle.”).
165. See, e.g., Peter Menell, Tailoring Legal Protection for Computer
Software, 39 STAN. L. REV. 1329, 1365, 1371 (1986) (arguing that operating
systems and application programs should receive shorter patent terms).
166. Uruguay Round Agreements Act, Pub. L. No 103-465, 108 Stat. 4809
(codified as amended in scattered sections of 15, 17, 19, and 35 U.S.C.).
167. Infra Part IV.A.1. In another research project, I use a separate natural
experiment related to TRIPS to measure the stock market value of additional
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data on maintenance fees.168 I discuss both measures in turn
below.
1. Patent Applicant Behavior Post-TRIPS
TRIPS was a landmark agreement that changed how patent
term was calculated for the first time in over 130 years.169 Before
TRIPS, a patent had a fixed, seventeen-year term that began
from the date the patent was granted by the PTO.170 The date an
inventor filed his patent application did not influence the length
of term he received.
After TRIPS, however, patent term became twenty years
from the date the application was filed.171 So post-TRIPS, the
prosecution time of an application reduced the total term a
patentee would receive. Accordingly, TRIPS created an incentive

years of patent term. In addition to changing patent term prospectively, TRIPS
also retroactively changed the term of already-existing patents based on their
previous prosecution time. In particular, TRIPS gave patentees of alreadyissued but not-expired patents the greater of (a) their current term (which was
awarded under the old rules) and (b) the term the patentee would have received
under the new rules. See id. at § 154(c)(1) (adjusting term on outstanding
patents). I take advantage of this unanticipated term increase by testing how
much publicly traded firms’ stock market values increased based on the total
amount of additional term those firms received.
168. Infra Part IV.A.2. This measure is not related to TRIPS.
169. See The Agreement on Trade-Related Aspects of Intellectual Property
Rights, PATENTLENS, http://www.patentlens.net/daisy/patentlens/415.html (last
visited Sept. 24, 2014) (on file with the Washington and Lee Law Review).
TRIPS also changed some rules on establishing an invention date and allowed
term extensions in some limited circumstances involving patent interference
proceedings, secrecy orders, or successful appellate reviews. Additionally, TRIPS
generated a new type of patent application known as a provisional patent
application, which is a simplified application that establishes a priority date for
an applicant. See Sukhatme & Cramer, supra note 10, at 34 (discussing
provisional patent applications). In my empirical paper, I address each of these
changes and explain why they do not confound my results.
170. See 35 U.S.C. § 154 (1988) (current version at 35 U.S.C. § 154(a)(2)
(2012)) (“Every patent shall . . . grant to the patentee . . . for the term of
seventeen years . . . .”).
171. See id. § 154(a)(2) (“[S]uch grant shall be for a term beginning on the
date on which the patent issues and ending 20 years from the date on which the
application for the patent was filed . . . .”).

REGULATORY MONOPOLY

1903

to speed up patent prosecution because prosecution time would
now eat into total patent term.172
My hypothesis is simple: an applicant who especially cares
about patent term is more likely to speed up prosecution postTRIPS as compared to an applicant who cares less about patent
term. Put differently, industries in which term is more important
will see average prosecution time decrease more than industries
in which term is less important. So by measuring how much
applicants sped up patent prosecution across different industry
groups, we can get a relative sense of how much they value
patent term.
It is not that easy, however, to measure applicant delay
during patent prosecution. This is because prosecution is a backand-forth process between the applicant and the PTO, so total
prosecution time depends both on applicant delay and PTO delay.
To illustrate, after an applicant files his application, the ball is in
the PTO’s court. The applicant then waits for the PTO to issue an
office action, in which the agency either accepts or rejects the
patent claims.173 If the applicant receives a rejection, he usually
has three months to respond to the office action, though he can
pay a fee and request an extension (which is almost always
granted) to extend his response time to six months.174
So to accurately measure applicant delay, one must parse out
prosecution time that is attributable to the applicant versus time
172. David Abrams wrote what appears to be the only other paper that uses
TRIPS as a natural experiment. David S. Abrams, Did TRIPS Spur Innovation?
An Analysis of Patent Duration and Incentives to Innovate, 157 U. PA. L. REV.
1613, 1613–17 (2009). He suggested patent classes with shorter average
pendencies (i.e., time between application filing and issuance) would benefit
disproportionately from the change in law because they would receive longer
patent term extensions on average after TRIPS. See id. at 1635 (“This indicates
that patent classes with longer extensions due to TRIPS tended to have a
greater increase in patents following TRIPS than those classes with shorter
extensions.”).
173. See 37 C.F.R. § 1.104 (2013) (describing the actions an examiner may
take).
174. See id. § 1.134 (“Unless the applicant is notified in writing that a reply
is required in less than six months, a maximum period of six months is
allowed.”); id. § 1.136(a) (stating that applicant may request to extend the time
period to reply if the original time period was less than the maximum period set
by statute).
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attributable to the PTO. I accomplish this by looking at detailed
transaction histories for 331,162 issued patents filed in 1994
through 1996. These histories, which chronicle every major event
during prosecution, allow me to parse out measures of applicant
delay, such as the amount of time an applicant takes to respond
to an office action, the number of extensions requested by an
applicant, and the amount of time an applicant takes to pay an
issue fee once he receives a notice of allowance.175
After generating these measures, I test how they changed
before and after TRIPS within different industry categories,
which lets me assess the relative importance of patent term
across industries. For example, if applicants in industry X
respond to TRIPS by speeding up their office action responses
more (or requesting fewer extensions) than applicants in industry
Y, that suggests patent term is more important in industry X
than in industry Y. Additionally, I compare these measures with
one another and perform numerous robustness checks, and I find
my results are consistent across specifications.176
The first column of Table 1 (titled “Coeff”) in the Appendix
shows the results from one of my specifications.177 This column
shows how applicants within particular industry subcategories178

175. See Sukhatme & Cramer, supra note 10, § 3 (conducting a statistical
analysis based on these factors).
176. Details on these robustness checks are in the full empirical paper, but
just to give an example, one might be concerned that some applicants might
have anticipated the passage of TRIPS and changed their prosecuting behavior,
which could skew measures of applicant delay. To address this selection
concern, in some specifications I exclude data in certain “inner windows” around
the enactment of TRIPS, such as applications filed in 1995 or applications filed
between December, 8, 1994 (the date TRIPS was enacted) and June 8, 1995 (the
date TRIPS went into effect). Id. at 28. Results generally remain similar and
significant across these specifications. See id. at 28–31 (showing results).
177. Infra Table 1.
178. When a patent is filed, it is assigned to a patent class by the PTO. The
industry subcategories shown here are higher-level groupings of these patent
classes. The subcategories were generated for a National Bureau of Economics
Research database. See Bronwyn H. Hall, Adam B. Jaffe & Manuel Trajtenberg,
The NBER Patent Citation Data File: Lessons, Insights and Methodological
Tools 414–16 (Nat’l Bureau of Econ. Research, Working Paper No. 8498, 2001)
(discussing the creation of the patent categories and subcategories).
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changed their prosecution speed after TRIPS went into effect.179
A negative value indicates that applicants in an industry sped up
prosecution on average after TRIPS; a positive value indicates
that they slowed down prosecution.
To illustrate, we see a coefficient of “−5.22” for the
“Information Storage” subcategory.180 This coefficient suggests
these applicants sped up patent prosecution, on average, by about
5.22 days post-TRIPS. Compare that to “Drugs,” which has a
coefficient of −8.55.181 This coefficient is significantly more
negative, which suggests that applicants in this industry sped up
prosecution more than those in “Information Storage.”
Notice that almost all the coefficients in column 1 are
negative.182 This is what we predicted—because prosecution time
reduces patent term after TRIPS, applicants will generally speed
up prosecution.183 Also notice the subcategories with statistically
significant coefficients in which patent applicants sped up the
most are the following:184
Genetics (−25.75)
Drugs (−8.55)
Semiconductor Devices (−7.36)
Electronic Business Methods and Software (−6.39)
Information Storage (−5.22)
179. TRIPS went into effect on June 8, 1995, six months after it was ratified.
The main independent variable I use in my regressions is a dummy variable
that takes the value “1” if the patent application was filed post-TRIPS (on or
after June 8, 1995) and “0” if the application was filed pre-TRIPS (before June 8,
1995). The Post-TRIPS coefficient is the ordinary least squares coefficient on
this variable. It measures how much applicants sped up after TRIPS.
180. Infra Table 1.
181. Infra Table 1.
182. Infra Table 1.
183. Mark Lemley first made this prediction in a paper he wrote twenty
years ago. See Mark A. Lemley, An Empirical Study of the Twenty-Year Patent
Term, 22 AIPLA Q.J. 369, 386–87 (1994) (hypothesizing that patent attorneys
will be pressured to file responses to office actions more quickly and therefore
reduce the prosecution time on patent applications). My empirical paper is the
first to apportion prosecution time between the applicant and the PTO; it is
therefore the first paper to test (and confirm) his prediction. See Sukhatme &
Cramer, supra note 10, at 2 (overviewing methods used).
184. Infra Table 1. See also Sukhatme & Cramer, supra note 10, at tbls.6–7.
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Computers—Hardware and Software (−5.03)
Resins (−4.99)
Communications (−4.87)
Organic Compounds (−4.86)
Computer Peripherals (−4.17)
Power Systems (−2.51)
Miscellaneous Chemicals (−2.40)

Many of these results support the conventional wisdom. For
example, it is not surprising that two prominent pharmaceuticalrelated subcategories (“Genetics” and “Drugs”), chemical
subcategories (“Resins” and “Organic Chemicals”) and
“Semiconductor Devices” were among the groups in which
inventors sped up prosecution the most. More surprising is the
presence of “Electronic Business Methods and Software,”
“Information Storage,” and “Computer—Hardware and Software”
as the subcategories with the fourth-, fifth- and sixth-fastest
speed-ups in prosecution, respectively. That applicants in these
fields responded more to TRIPS suggests inventors of new
software products and business methods might care more about
patent term than was previously appreciated.
2. Maintenance Fee Measure
There are other empirical measures of patent value that do
not rely on natural experiments. The second column of Table 1
(titled “Mtd”) presents such a measure based on maintenance fee
payments.185 As discussed previously, maintenance fees must be
paid by a patentee to prevent a patent from lapsing.186 The
measure presented here is the percentage of patentees within an
industry category who maintain their patents through the last
maintenance fee payment, due eleven-and-a-half years after
patent issuance. In other words, column two reports the

185.
186.
fees).

Infra Table 1.
See supra notes 94–95 and accompanying text (discussing maintenance
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percentage of patents within industry subcategories whose patent
term did not end early for failure to pay maintenance fees.187
I use this maintenance fee measure as another way to
compare the relative value of patents across industries.188 The
idea is that if a patentee pays a maintenance fee, we can infer he
believes the discounted expected benefit from keeping the patent
alive exceeds the present cost of the maintenance fee. If more
patents are renewed in certain industries relative to others, we
can conclude patent term is, on average, more valuable in those
industries. For example, if pharmaceutical patents are more
likely to be maintained on average than mechanical patents, then
we might believe that pharmaceutical patents are on average
more valuable than mechanical patents.
Of course, there are limitations to this approach because
patents that are maintained are only the ones near the top end of
the patent value distribution—those patents whose value exceeds
the maintenance fee threshold amount. Conclusions drawn from
maintenance fees might not hold true for less valuable patents
within an industry.189 Nonetheless, cross-industry renewal rates
offer some insight as to the average patent value within those
industries.
Looking at Table 1, we can see that subcategories with
renewal rates greater than 50% are the following:190
187. Infra Table 1.
188. Other scholars have also used data on maintenance fee payments as a
proxy for patent value. See Jean O. Lanjouw, Ariel Pakes & Jonathan Putnam,
How to Count Patents and Value Intellectual Property: The Uses of Patent
Renewal and Application Data, 46 J. INDUS. ECON. 405, 407 (1998) (noting that
because “patent rights are seldom marketed, application and renewal data are
one of the few sources of information on the value of patent protection
available”); Mark Schankerman, How Valuable is Patent Protection? Estimates
by Technology Field, 29 RAND J. ECON. 77, 78 (1998) (“Under the assumption
that patentees make a profit-maximizing renewal decision, data on patent
renewal rates and fees can be used to infer the private value of patent
protection.”).
189. See, e.g., David S. Abrams, Ufuk Akcigit & Jillian Popadak, Patent
Value and Citations: Creative Destruction or Strategic Disruption?, 27 (PIER
Working Paper 13-065, 2013), available at http://papers.ssrn.com/
sol3/papers.cfm?abstract_id=2351809 (finding an inverted-U relationship
between forward citations and patent value).
190. Infra Table 1. Based on percentage of issued patents filed in 1994–1996
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Electronic Business Methods and Software (64.6%)
Semiconductor Devices (63.8%)
Computer Peripherals (62.7%)
Genetics (61.7%)
Computers ― Hardware and Software (60.7%)
Communications (60.7%)
Information Storage (60.4%)
Surgery & Medical Instruments (57.8%)
Miscellaneous Electronics (57.0%)
Miscellaneous Drugs and Medical (53.5%)
Power Systems (53.0%)
Nuclear & X-rays (51.8%)
Electrical Devices (51.7%)
Resins (50.6%)
Optics (50.1%)

We can see significant overlap between the subcategories
here and the ones where patent applicants sped up prosecution
the most after TRIPS. For example, “Genetics,” “Semiconductor
Devices,” and “Electronic Business Methods and Software,” rank
highly under both measures.191 This overlap suggests the two
measures are capturing a real effect and that patent term indeed
matters more in these subcategories.192
3. Industry-Level PTO Costs
The discussion here has thus far focused primarily on
patentees: how much does patent term matter to patentees in
different industries? A related, important question relates to the
and maintained through eleven-and-a-half years. See Sukhatme & Cramer,
supra note 10, at tbls.6–7.
191. Infra Table 1.
192. One can also run quantitative tests to confirm the two measures are
highly correlated. In my paper, I use more advanced empirical methodologies
(including one technique known as difference-in-differences estimation) and
multiple controls to confirm the correlation between the two measures. See
Sukhatme & Cramer, supra note 10, § 5 (using a difference-in-differences
analysis to test the relationship between patent renewal rates and changes in
applicant delay due to TRIPS).
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PTO: does it cost more for the PTO to examine certain types of
applications as compared to others?
It turns out it does. In particular, the PTO allocates a certain
number of hours for patent examiners to review applications
within different technology groups.193 In a recent empirical piece,
Michael Frakes and Melissa Wasserman generated examiner
hour estimates for the same industry subcategories I have
discussed throughout this section.194 These hour estimates are
shown in column 3 of Table 1 (titled “Hours”).195
Looking at these estimates, we can identify the subcategories
that cost the PTO the most in terms of examiner hours spent
reviewing applications. In particular, here are the subcategories
for which the PTO allocates more than twenty hours of
application review time:196
Electronic Business Methods and Software (27.4)
Genetics (24.8)
Computers—Hardware and Software (23.4)
Computer Peripherals (21.9)
Gas (21.7)
Coating (20.9)
Semiconductor Devices (20.6)
It is striking that the subcategories here are largely the same
ones that topped the previous two lists in this section. In other
words, the subcategories in which applicants care the most about
patent protection are the same as the subcategories that cost the
PTO the most in terms of application review time.
The overlap between these measures further bolsters the
case for differential pricing. As discussed earlier, it makes sense
193. See Frakes & Wasserman, Failed Promise, supra note 11, app. A, at 9
(noting that the PTO assigns a certain amount of hours to examine a patent
depending on the technology group a patent is in and the examiner’s pay grade).
194. See id; Frakes & Wasserman, PTO’s Granting Patterns, supra note 11,
app. A, at 135–36 tbl.A1 (listing technology categories). In particular, these
authors showed how many hours were allocated to an examiner to review a
patent application within each of the same thirty-seven subcategories I use
here. Id.
195. Infra Table 1.
196. Frakes & Wasserman, PTO’s Granting Patterns, supra note 11, app. A,
at 135–36 tbl.A1.
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for the PTO to use its regulatory monopoly status to charge
higher fees to: (1) applicants who value patent protection more;
and (2) applicants for whom examination takes more time by the
PTO. The above discussion tells us that these two groups are
often in fact the same ones.197 In other words, the subcategories
in which applicants care more about patent protection are the
same ones that have more costly applications to review.198
B. Generating Differential Patent Prices
The previous section showed two independent ways of
measuring patent term sensitivity, which informed us of the
relative importance of patent term across industries.199
Additionally, we saw how the subcategories in which applicants
cared the most about patent term were the same subcategories
with applications that cost the PTO the most to review.200
Next, we can use our patent sensitivity measures to generate
differential patent prices. In particular, as described in Part III,
the optimal approach likely involves scaling the third
maintenance fee (due at eleven-and-a-half years) by the
applicants’ measured desire for patent protection. There are a
number of ways in which differential prices could be generated
but I focus on two examples presently.201
197. Calculation of correlation coefficients confirms these measures are
related.
198. Michael Frakes and Melissa Wasserman also develop a more
complicated measure of examination costs by subcategory. See Frakes &
Wasserman, Failed Promise, supra note 11, app. A, at 9–11 (detailing
construction of examination cost measure). This measure accounts for examiner
salaries and the distribution of GS pay grades across subcategories. Id. The
relative ranking of subcategories under either the hours-spent measure (as
shown in column 3 of Table 1) or the Frakes–Wasserman cost measure is almost
identical, and both correlate with my applicant delay and maintenance fee
measures. Compare Table 1 (measuring change in patent prosecution delays and
percent of patents maintained), with Frakes & Wasserman, Failed Promise,
supra note 11, app. A, at 135–36 tbl.A1 (measuring examination costs by
technology).
199. Supra Part IV.A.1–2.
200. Supra Part IV.A.3.
201. The fees discussed in this subpart are the default ones for large entity
patentees; as noted, small entities and micro-entities pay one-half and one-
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First, one simple way to generate prices would be to use the
desired measure itself to scale the eleven-and-a-half year
maintenance fee. This could be done for all the industries, or just
a subset of them. For example, one could increase maintenance
fees only on applicants in industries that had a significant
negative coefficient on the “Post-TRIPS” measure described in
Part III.A.1. In other words, fees would increase only on
patentees in the twelve subcategories with significant negative
coefficients because those applicants responded the most to the
change in patent term instituted by TRIPS.202
How large should this fee increase be? One straightforward
approach would be to generate the increase based on the
deviation of the relevant coefficient from zero. To illustrate,
“Communications” has a coefficient of −4.87; hence, we could
increase maintenance fees in “Communications” by 4.87% relative
to the current maintenance fee of $7,400.203 Column 1 of Table 2
(titled “Prop 1”) shows the proposed increases under this
approach. As one can see, it involves only modest increases, with
a maximum increase of just $1,906 for “Genetics.”204
This approach could also be altered to accommodate larger
fee increases. For example, suppose the PTO calculates
differential prices based on the second measure described in the
previous section—the percentage of applicants within industry
subcategories who maintained patents through eleven-and-a-half
years (values in column 2 of Table 1, titled “Mtd”).205
Subcategories with more maintained patents will have patentees
who typically care more about patent protection. That is, their

quarter of these fees, respectively. See 35 U.S.C. § 41(h) (2012) (setting forth the
fees charged to small entities).
202. Infra Table 1.
203. Infra Table 1; see 37 C.F.R. § 1.20 (2013) (setting the current
maintenance fee).
204. Infra Table 2.
205. See supra Part IV.A.2 (arguing that patentees in industries that tend to
maintain patents through eleven-and-a-half years generally value patent
protection more than patentees in industries that do not maintain patents for
the same time period).
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demand for patents is likely to be more inelastic, so individuals in
those subcategories could be charged higher maintenance fees.206
To illustrate how this approach might be implemented,
suppose the PTO decides to keep the eleven-and-a-half year
maintenance fee at $7,400 for applicants in the subcategory with
the lowest renewal rate (“Furniture and House Fixtures,” which
only has a 27.94% renewal rate) but increases fees
proportionately for everyone else. Then, for example, “Electrical
Device” patentees, who have a 51.65% renewal rate, would see
their fees increase by 23.71% (51.65% minus 27.94%), and
“Organics Compound” patentees, who have a renewal rate of
44.30%, would see their fees increase by 16.36% (44.30% minus
27.94%).207 This approach would yield a fee schedule as shown in
the second column of Table 2 (titled “Prop 2”).208 The fee increases
in Proposal 2 cover all subcategories of inventions and are larger,
ranging up to an increase of $2,711 for “Electronic Business
Methods and Software.”209
The approaches described here are flexible and could be
altered in a number of ways. For example, instead of targeting
maintenance fees at the subcategory level, one could tailor them
at the broader category level (i.e., the six categories of
“Chemicals,” “Drugs and Medical,” “Others,” “Electrical,”
“Computers and Communications,” and “Mechanical”).210
206. See ELASTICITY ESTIMATES, supra note 115, at 1 (explaining that
inelastic demand means that consumers are generally indifferent to changes in
price).
207. Infra Table 1.
208. Infra Table 2.
209. Infra Table 2. The proposals here show how the PTO could use
differential maintenance fees to charge more to patentees who care more about
patent term. As discussed in Part III.E above, differential patent pricing could
also be used to limit patent term by increasing maintenance fees to such a
degree that few patentees renew their patents. For example, to limit patent
term on “Optics” to three-and-a-half years, the PTO could increase the
three-and-a-half year patent term by some large value (e.g., a ten-fold increase)
to effectively limit term for most “Optics” patentees.
210. One might be concerned about patentees “gaming” the system by
writing their applications in such a way as to take advantage of lower fees.
Differentially pricing along larger category boundaries would make this more
difficult. For example, an inventor might be able to frame his application as an
“Information Storage” invention instead of a “Computer—Hardware and
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Alternatively, fees could be set at the finer patent class level,
which is determined by the PTO when a patent application is
filed.
Still, it is apparent there is some guesswork in the tailoring
of maintenance fees. In particular, it might not always be clear
whether fee adjustments are too high or too low for a particular
subcategory. Fortunately, this concern is surmountable because
differential patent prices can be adjusted over time. If, for
example, the PTO notices that patentees severely decrease the
number of patents renewed in response to a modest increase in
maintenance fees, then that suggests the increase in
maintenance fees was too much. On the other hand, if patentees
barely respond to the increase in maintenance fees—if they
maintain their patents at approximately the same rate as
before—then that suggests a further increase in maintenance fees
might be appropriate. Accordingly, the PTO has significant
ability to tweak prices as needed to ensure it achieves its goals of
increasing revenue and incentivizing innovation.
V. The Legal Basis for Differential Patent Pricing
This Article thus far has shown how differential pricing could
improve social welfare, and how such prices might be set across
different industry categories. The present Part discusses the legal
authority for the PTO to set such prices. In particular, the Article
explains how many of the changes specified above could be
implemented by the PTO using newly gained fee-setting
authority under the America Invents Act of 2011.
A. The America Invents Act and the PTO’s Fee-Setting Authority
Until recently, the PTO had little control over the fees it
charged patent applicants or patentees. Filing fees, maintenance
fees, or other fees owed to the PTO were set by statute, and any
Software” invention to avoid higher maintenance fees in the latter subcategory.
But it would be much harder for him to frame his application such that it falls
outside the broader, “Computer and Communications” category.
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change to these fees needed to be approved by Congress.211
Moreover, since 1991, Congress has effectively required the PTO
to fund itself through these user fees.212
This situation was problematic. If the PTO must fund itself
but has no control over what it can charge, then as its workload
increases, it might take extraordinary measures to ensure it
stays within budget. Indeed, Michael Frakes and Melissa
Wasserman recently suggested that the PTO did this by granting
more patents in areas that tended to have higher renewal rates
(and hence, more maintenance fees to collect),213 and by
prioritizing patent applications in technologies that are quicker to
review (and hence, allowing the PTO to churn through
applications quicker and earn more fees).214
Things changed in 2011, when the PTO was given fee-setting
authority with the passage of the America Invents Act (AIA).215
The AIA was the culmination of years of scholarly and legislative
debate on patent reform. It resulted in numerous changes to the
patent system, most notably a shift from a first-to-invent to a
first-to-file system of patent priority, so a patent application filing
date and not the actual invention date is now what determines

211. See 35 U.S.C. § 41 (2012) (setting fees for patent applications).
212. See Frakes & Wasserman, PTO’s Granting Patterns, supra note 11, at
76 (discussing the funding of the PTO through user fees).
213. See id. at 102–05 (finding their results are consistent with the general
prediction that the PTO would more likely grant patents in categories with a
high maintenance fee renewal rate). The PTO recently disputed this assertion,
claiming that higher renewal rates in particular industries have no effect on its
patent granting decisions. See Setting and Adjusting Patent Fees, 78 Fed. Reg.
4211, 4251 (Jan. 18, 2013) (“[T]he Office’s fee schedule and financial positions
are not the drivers of patent examination practice . . . . [P]atent examiners
make independent patentability determinations in accordance with statutory
requirements by comparing the prior art to the claimed invention as a whole,
without regard to budgetary pressures of the USPTO.”).
214. See Frakes & Wasserman, Failed Promise, supra note 11, at 5 (finding
that when the PTO is in financial difficulty, it begins to give “preferential
examination-queuing treatment to those technologies that cost the Agency the
least to examine”).
215. See Leahy–Smith America Invents Act, Pub. L. No. 112-29, 125 Stat.
284 (2011) (codified in scattered sections of 35 U.S.C.) (giving the PTO limited
fee-setting authority).
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who has priority among different inventors who claim the same
invention.216
More importantly for our purposes, the AIA gave the PTO
control over the fees it charges. The most important AIA
provision relevant to fee-setting is § 10(a), which allows the PTO
to “set or adjust by rule any fee” for patent-related services or
materials provided by the PTO, so long as any such change is
used “to recover the aggregate estimated costs to the Office for
processing, activities, services, and materials relating to
patents.”217 In other words, the PTO can alter its fees, but the
changes must be related to the PTO’s actual costs—the goal is for
the PTO to have sufficient flexibility to take care of its own
expenses, not to turn it into a money-making machine.
Moreover, § 10(d) of the AIA specified procedures the PTO
must take before it can exercise its fee-setting authority. First,
the PTO Director must submit a proposed fee to the nine-member
Patent Public Advisory Committee, which was first created by the
American Inventors Protection Act of 1999.218 The Director must
engage the Committee at least forty-five days before publishing
the proposed rule and ensure the Committee has thirty days to
216. The AIA also eliminated patent interferences, which were proceedings
used by the PTO to determine priority between different inventors. Id. §§ 134,
145, 146, 154, 305. Additionally, the AIA gave outside parties the ability to
challenge patents in the PTO for up to nine months after the patent issues. Id.
§ 321.
217. 35 U.S.C. § 41(d)(1)(A). The full provision as it relates to patents states:
(a) FEE SETTING
(1) IN GENERAL. The Director may set or adjust by rule any fee
established, authorized, or charged under title 35, United States
Code, . . . for any services performed by or materials furnished by, the
Office, subject to paragraph (2).
(2) FEES TO RECOVER COSTS. Fees may be set or adjusted under
paragraph (1) only to recover the aggregate estimated costs to the
Office for processing, activities, services, and materials relating to
patents (in the case of patent fees) . . . including administrative costs
of the Office with respect to such patent . . . fees (as the case may be).
Id.
218. See 35 U.S.C. § 5(a) (establishing the Advisory Committee). The
Committee is selected by the Secretary of Commerce and consists of individuals
“chosen so as to represent the interests of diverse users of the [PTO] with
respect to patents.” Id. § 5(b).
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consider the fee proposal.219 The Committee must hold a public
hearing during this thirty-day period and produce a public
written report of its comments, advice, and recommendations,
which the Director must then consider.220
If the Director decides to proceed with the fee change, she
must notify Congress (via the Chair and Ranking Member of the
Committees on the Judiciary of the Senate and the House of
Representatives) about the proposed change and publish the
proposed fee in the Federal Register, describing its rationale and
possible benefits.221 After a public comment period of at least
forty-five days, the Director can then publish a final rule in the
Federal Register and Official Gazette of the PTO.222 Absent a
congressional override, the new fee can then go into effect at “the
end of the forty-five day period beginning on the day after the
date” on which the final rule was published.223
Section 10(c) of the AIA also gave the PTO the ability to
reduce fees in certain fiscal years, provided the PTO Director
consults with the Patent Public Advisory Committee on the
advisability of reducing these fees first.224 So the Director does
not have to go through the general notice and comment procedure
described in the paragraphs above if the change is just a
reduction in fees.
B. Differential Patent Pricing Under the AIA
There is good reason to believe the PTO can use its § 10
authority to set differential patent prices across industry
categories. Although the statute mandates certain pre-fee-setting
procedures, it gives the PTO a great deal of flexibility in actually
219. See Leahy-Smith America Invents Act, Pub. L. No. 112-29, § 10(d)(1),
(2)(A), 1245 Stat. 284, 317 (2011) (requiring the Committee’s input on fee
changes).
220. See id. § 10(d)(2)(B), (d)(3), (d)(4) (providing notice and comment
proceedings for proposed fee changes).
221. See id. § 10(e)(4) (implementing notification requirements for fee
changes).
222. See id. § 10(e)(3) (providing public hearing for fee changes).
223. Id. § 10(e)(4)(A).
224. See id. § 10(c) (allowing for fee reductions in certain fiscal years).
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setting the fees. Indeed, the PTO has the final say over what fees
are implemented.
In particular, the statute allows the agency to set or adjust
any fee to recover its aggregate estimated patent-related costs.225
There is no requirement that each PTO technology group or
division subsist on its own budget; rather, the agency is free to
choose fees and reallocate funds to best enable it to meet its
aggregate expected patent-related costs.
Additionally, the PTO has already recognized its ability to
use fee setting to promote innovation. For example, when the
PTO first exercised its new fee-setting authority in 2013, it noted,
“To encourage innovators to take advantage of patent protection,
the Office sets basic ‘front-end’ fees (e.g., filing, search, and
examination) below the actual cost of carrying out these
activities.”226 Differential patent pricing on maintenance fees is
merely a more efficient way for the PTO to do what it already
does: increase back-end revenues to subsidize lower front-end
fees.227
225. See id. § 10(a)(2) (“Fees may be set or adjusted . . . only to recover the
aggregate estimated costs to the Office . . . .”).
226. Setting and Adjusting Patent Fees, 78 Fed. Reg. 4211, 4216 (Jan. 18,
2013). The Patent Public Advisory Committee also recognized that the AIA
grants the PTO power to shape patent applicant behavior through fee
structuring. See U.S. PATENT & TRADEMARK OFFICE, PATENT PUBLIC ADVISORY
COMM.
FEE
SETTING
REPORT
6
(2012),
http://www.uspto.gov/aia_
implementation/120924-ppac-fee-setting-report2.pdf (“Within the ambit of
overall aggregate revenue recovery, the AIA allows the USPTO to set individual
fees at levels to encourage or discourage behaviors by applicants.”).
227. One potential concern with industry-specific tailoring relates to a
provision in TRIPS, which prohibits member states from discriminating in
granting patents based on technology type. See Trade-Related Aspects of
Intellectual Property Rights, Art. 27, PATENTLENS, http://www.patentlens.net/
daisy/patentlens/415.html (last visited Sept. 24, 2014) (“[P]atents shall be
available and patent rights enjoyable without discrimination as to the place of
invention, the field of technology and whether products are imported or locally
produced.”) (on file with the Washington and Lee Law Review). This provision,
however, has never been carefully followed by the United States or the
European Union. See BURK & LEMLEY, supra note 131, at 97. For example, the
United States has passed numerous industry-specific statutes, particularly in
relation to pharmaceuticals, biotechnology, and semiconductors. See id. at 95–96
(citing nine industry-specific U.S. statutes, including 35 U.S.C. §§ 155, 156
(2000) (lengthening term for most pharmaceutical patents); 35 U.S.C. § 103(b)
(2000) (relaxing obviousness standard for biotechnological processes); 17 U.S.C.
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Furthermore, as discussed in Part IV.A.3 above, the industry
subcategories in which patentees care more about patent
protection correspond quite closely to the subcategories that cost
the PTO the most in terms of examiner resources. So differential
maintenance fees can also be justified as a way to deal with
differential costs across industry subcategories. For example, a
higher maintenance fee on the “Genetics” subcategory is justified
not only because applicants in that category generally care more
about patent protection (and hence are likely to pay more for
patent protection) but also because it costs the PTO more to
review a “Genetics” application. So increasing the back-end fees
charged to “Genetics” patentees takes into account that these
individuals are imposing higher costs on the PTO in the first
place.
Although the PTO can likely use its § 10 authority to
differentially price maintenance fees across industries, it is less
clear whether it could use the same authority to differentially
limit patent term. As discussed in Part III.E.2 above, the PTO
could effectively limit patent term on an industry-by-industry
basis by greatly increasing maintenance fees for patentees in
some industries. This sort of policy would not be an attempt by
the PTO to generate revenue to reduce other costs;228 rather, such
an increase would further the direct policy objective of limiting
excess term in some industry categories. It seems likely that such
an increase would be too much of a stretch of the PTO’s § 10
authority.229 Hence, further congressional action might be
§ 901-14 (2000) (Semiconductor Chip Protection Act)). Indeed, TRIPS has never
been enforced against countries for enacting industry-specific statutes, and as a
practical matter, modest tailoring like the customized maintenance fees
described here seems likely to be compatible with TRIPS. See id.; see also Roin,
supra note 14, at 706 n.155 (suggesting industry-specific patent terms would not
violate TRIPS); Graeme B. Dinwoodie & Rochelle C. Dreyfuss, Diversifying
Without Discriminating: Complying with the Mandates of the TRIPS Agreement,
13 MICH. TELECOMM. & TECH. L. REV. 445, 453 (2007).
228. Indeed, unless current maintenance fees are tremendously underpriced,
one might expect a very large increase in maintenance fees would end up
decreasing PTO revenues.
229. See U.S. PATENT & TRADEMARK OFFICE, supra note 226, at 6
As a policy matter, the PPAC advised that while some use of fees to
encourage or discourage behavior may be appropriate, significant use
of this ability to set fees at very high levels to discourage actions is
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necessary before the PTO could greatly increase maintenance
fees as a way to effectively limit patent term.230
Even if such legislation is required, however, that has no
impact on the benefits of limiting patent term in the manner
described here. In particular, recognizing that increasing patent
maintenance fees is a more flexible way to differentially limit
term is an insight that policymakers should remember if they
ever seek to institute industry-specific patent terms.
VI. Conclusion
There is a hidden monopoly that lies dormant within many
regulatory bodies. This Article tries to shed light on that
monopoly and reveal its power to conduct differential pricing. In
particular, the Article describes the economic factors that give
regulatory monopolists the ability to price regulatory “goods”
differentially and explains how these monopolies can use such
pricing to enhance social welfare.
The Article proceeds to apply these concepts to the market
for patents. The PTO is a quintessential regulatory monopoly,
with the sole power to provide a regulatory good (i.e., patent
rights) and set related prices (i.e., patent fees). The Article
explains how the PTO could differentially price patents across
industries to increase revenues and promote innovation.
Additionally, it describes how differential pricing of maintenance
fees provides a flexible way to achieve a policy goal sought by
many scholars: the customization of patent terms across
industries.

not recommended because it is not clear that the USPTO will always
take into consideration the factors driving applicants to certain
behaviors, which may be at cross-purposes with particular desires of
the USPTO.
230. If a huge increase in maintenance fees were applied to already-issued
patents, there might also be an argument that this increase constitutes a
regulatory taking under the Fifth Amendment of the U.S. Constitution. See, e.g.,
Lucas v. S.C. Coastal Council, 505 U.S. 1003, 1019 (1992) (stating that a
regulation that deprives a property owner of all economically beneficial uses of
her property constitutes a regulatory taking).
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The Article then details my recent empirical work, which
provides the foundation for setting differential patent prices. In
particular, my research measures the relative importance of
patent term to applicants and patentees in different industries. I
approach this question from different empirical angles and find
consistency in my results. This consistency provides comfort that
we have indeed identified the industries in which patent term is
more important. Using these results, I then generate examples of
differential pricing structures.
The last section of the Article describes the legal framework
for differential pricing. Namely, it describes how the AIA—the
recent manifestation of a years-long push toward patent reform—
empowers the PTO to set different prices for patentees in
different industries.
Differential pricing is not necessarily easy to implement, nor
is it always desirable. Nonetheless, regulatory monopolies would
do well to recognize that such pricing can be a powerful tool that
enables agencies to better fulfill their regulatory goals. This is
particularly true in the market for patents, where differential
pricing has the potential to make the U.S. patent system better at
achieving its core purpose: Incentivizing innovation.

REGULATORY MONOPOLY

1921

VII. Appendix
Table 1: Post-TRIPS Coefficients, Percent of Patents Maintained,
and Examination Hours Allocated by PTO Across Subcategories231
Category
Chemicals
Agriculture, Food,
Textiles
Coating
Gas

Coeff

Mtd

Hrs

Category

Coeff

Mtd

Hrs

19.3

1.11

41.4

19.1

0.80

45.9

19.2

−0.28

45.6

18.4

1.07

47.8

20.9

Mechanical
Material Proc. &
Handling
Metal Working

0.92

44.4

21.7

Motors/Engines

−2.00

36.7

Organic Comp.

−4.86***

44.3

18.8

Optics

−2.20

50.1

17.1

Resins

−4.99***

50.6

19.3

Transportation

−1.23

36.2

16.9

Misc.

−2.40***

45.9

18.8

Misc.

1.39

41.1

17.9

−8.55***

48.8

17.2

Communications

−4.87***

60.7

18.9

1.65

57.8

15.3

Hard./Software

−5.03***

60.7

23.4

−25.75***

61.7

24.8

Comp. Periph.

−4.17***

62.7

21.9

53.5

18.8

Info. Storage
Elec. Bus. Meth. &
Software

Comp. & Comm.

Drugs & Med.
Drugs
Surgery/Med. Inst.
Genetics
Misc.

−1.45

−5.22***

60.4

14.2

−6.39***

64.6

27.4

Others
Agric., Husb., Food
Amuse. Devices

−0.61
4.50***

35.6

18.5

28.6

17.2

Electrical
Elec. Devices

−1.18

51.6

17.8

Apparel & Textile

−1.90

30.4

17.3

Elec. Lighting

−1.40

41.5

18.7

Earth Work./Wells

1.50

49.5

17.6

Meas. & Testing

−1.99*

47.3

17.9

Furn., House Fix.

−1.02

27.9

16.6

Nuclear & X-rays

0.03

51.8

19.8

Heating

−1.00

40.5

13.8

Power Systems

−2.51**

53.0

18.7

Pipes & Joints

−0.49

47.8

16.6

Semiconductors

−7.36***

63.8

20.6

Receptacles

−1.10

33.0

15.3

Misc.

−0.74

57.0

17.6

Misc.

−0.91

40.9

18.4

231. First and second cols. (Coeff and Mtd) are from Neel U. Sukhatme &
Judd N.L. Cramer, Who Cares About Patent Term? Cross-Industry Differences in
Term Sensitivity (Princeton Univ. Econ. Dept., Working Paper, 2014) at tbls.6–
7, available at http://ssrn.com/abstract=2293245. ***P<0.01, **P<0.05, *P<0.1.
Third col. (Hrs) is from Michael D. Frakes & Melissa F. Wasserman, Does
Agency Funding Affect Decisionmaking?: An Empirical Assessment of the PTO’s
Granting Patterns, 66 VAND. L. REV. 65 app. A at 135–36 tbl.A1 (2013).
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Table 2: Proposed Differential Increases for
11 1/2 Years Maintenance Fee232

Category

Prop 1

Prop 1

Prop 2

$0

$994

$1,472

Mechanical
Material Proc. &
Handling
Metal Working

$0

$1,330

$1,216

Motors/Engines

$0

$1,305

$360

$1,211

Optics

$0

$1,641

$369

$1,679

Transportation

$0

$610

$178

$1,331

Misc.

$0

$973

$633

$1,540

Communications

$360

$2,423

$0

$2,210

Hard./Software

$372

$2,426

$1,906

$2,495

Comp. Periph.

$309

$2,572

$0

$1,889

Info. Storage
Elec. Bus. Meth. &
Software

$386

$2,403

$473

$2,711

Chemicals
Agriculture, Food,
Textiles
Coating

$0
$0

Gas

$0

Organic Comp.
Resins
Misc.

Prop 2

$645

Comp. & Comm.

Drugs & Med.
Drugs
Surgery/Med. Inst.
Genetics
Misc.

Category

Others
Agric., Husb., Food

$0

$570

Amuse. Devices

$0

$52

Elec. Devices

$0

$1,755

Apparel & Textile

$0

$181

Elec. Lighting

$0

$1,006

Earth Work./Wells

$0

$1,598

Furn., House Fix.

$0

$0

Electrical

Meas. & Testing

$0

$1,433

Nuclear & X-rays

$0

$1,767

Heating

$0

$928

Power Systems

$186

$1,856

Pipes & Joints

$0

$1,471

Semiconductors

$545

$2,657

$0

$2,150

Receptacles

$0

$373

Misc.

$0

$958

Misc.

232. The current eleven-and-a-half year maintenance fee is $7,400.
Proposals above show suggested increases in this fee, by subcategory.

